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ABSTRACT
Background
Induction of labour and caesarean delivery are common interventions in obstetric 
care and over the last decades both have been steadily increasing in frequency 
worldwide. The two interventions are concatenated, since many of the indica-
tions for either intervention often are the same, and approximately 20-40% of all 
inductions in first time mothers ends with a caesarean delivery. Women with a 
 caesarean delivery are in their next pregnancy and delivery at risk for both maternal 
and neonatal adverse outcomes. The aim of this thesis was to study the woman’s 
chances of a vaginal birth after a first caesarean delivery, and her risk of having 
a repeat caesarean, in the light of the previous reason for the first caesarean. And 
also study the risk of a negative birth experience depending on delivery mode after 
a trial of labour after caesarean. Predicting a woman’s probabilities of a vaginal 
birth could facilitate the antenatal decisions. Having a previous vaginal birth is 
one of the strongest predictors for a vaginal birth after caesarean. Delivery mode 
in women with only a caesarean delivery is more unpredictable. Therefore we 
aimed to develop a prediction model to predict vaginal birth in women with only 
a previous caesarean delivery. A further aim was to study the differences in time-
to-delivery, caesarean delivery rate, and other maternal and neonatal outcomes 
between different induction methods in nulliparous women with an unripe cervix.
Material and methods
In these population-based studies we used two different data cohorts based on 
pregnant women’s antenatal, delivery and postnatal electronic medical records. 
The Stockholm-Gotland Obstetric Cohort includes the whole population of women 
delivering in the region and includes approximately 25% of all births in Sweden. 
The study period was over 7 years, between 2008 and 2014 (Study I, II, IV). The 
Swedish Pregnancy Register is a new register that has been in use since 2013, today 
covering 98.5% of all deliveries in Sweden. In our cohort the women  studied had 
two following deliveries between 2014 and 2017 (Study III). In all four  studies all 
the pregnancies and deliveries were at or beyond term, with a singleton infant, in 
cephalic presentation and live born. The induced women in Study I were nullipa-
rous and in studies II, III and IV the women had one previous caesarean delivery. 
By using different regression analyses (linear, logistic and Poisson) we calculated 
time-to-delivery, adverse outcomes, risk of repeat caesarean, mean birth experience 
and risk of negative birth experience in study I, II and III. In study IV we used both 
regression and machine learning methods (conditional inference tree and random 
forest, lasso binary regression) to develop prediction models for predicting vaginal 
birth after caesarean.
Results
When labour was induced in first time mothers, compared to dinoprostone, an 
association of a 7 hour shorter mean time-to-delivery with balloon catheter was 
found, and 1.5 hour shorter mean time-to-delivery with misoprostol. The  caesarean 
delivery rates were high, but the different induction methods showed no  significant 
difference with regard to adverse outcomes. Of all women undergoing a trial of 
labour after caesarean, 69% had a vaginal delivery. Women with a first unplanned 
caesarean had increased risk of repeat caesarean compared to women with elec-
tive first caesarean (risk ratio 1.64, 95% confidence interval 1.43-1.89). With a 
 previous labour dystocia the risk of repeat caesarean in the second labour was 
almost twofold. In women with a history of labour dystocia the risk for repeat 
caesarean decreased with increasing cervical dilation at first delivery. Mean birth 
experience was rated high for all women, but having an unplanned repeat  caesarean 
was associated with an increased risk of negative birth experience. Machine 
learning and classical regression models had an area under the receiver-operating 
curve ranging between 0.61 to 0.69, with a high sensitivity and a low specificity 
in predicting vaginal birth in women with one previous birth, a caesarean delivery. 
Conclusions
To be induced with a balloon catheter is associated with a shorter time-to-delivery 
than prostaglandins. Induced women have high caesarean rates. Almost 70% of 
all eligible women deliver vaginally after a trial of labour after caesarean, even 
women with a history of labour dystocia have a good chance. Most women with 
a first caesarean score their next birth experience as positive, irrespective of the 
mode of delivery. However, having a repeat unplanned caesarean is associated 
with the risk of a negative birth experience. To predict vaginal birth after caesarean 
is difficult. All the models misclassified unplanned repeat CDs, the majority of 
individuals with an unplanned repeat CD in the second delivery, had a predicted 
probability of more than 60% chance of giving birth vaginally. 
Key words
Induction of labour, caesarean delivery, trial of labour after caesarean, vaginal 
birth after caesarean
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11 INTRODUCTION
To give birth is a unique event in a woman’s life. During pregnancy, I awaited 
 giving birth with great anticipation, delight and sometimes even with fear. After-
wards lying in bed with a completely new person in my arms was an  unbelievable 
feeling. I have given birth to this wonderful and beautiful little boy! Or have I 
really given birth? I had an unplanned caesarean delivery. Doubts about having 
given birth, a feeling of failure and a wish for revenge came to me stealthily. In 
next pregnancy I would show them!
During preparations for my next delivery I collected more information, went to 
evening events with different advice; Don’t use epidural anaesthesia! Stand upright! 
Don’t be passive! Full of revenge desire, I handled the first hours of strong con-
tractions well. However, after many hours of not enough progress of labour, we 
came to the operation theatre with the promise of an attempt of vacuum extrac-
tion. Another caesarean! What a failure! But still a wonderful girl! I was happy 
but at the same time sad. After two caesareans there would be no more chance of 
vaginal birth for me.
What are my reflections today, after four caesareans and four wonderful children 
nineteen years after that first birth? I wish I had had a dedicated, engaged and pre-
sent midwife at my first delivery, not a midwife overloaded with work, without 
enough time for me. I also wish that I had had an individual plan during the follow-
ing pregnancy, giving me evidence-based explanations and realistic expectations 
about the next birth. I also wish I had been induced in the first pregnancy instead 
of letting me wait until 43 full pregnancy weeks. However, I am very happy and 
fortunate that at the end, I have four healthy children and have experienced no 
adverse outcomes, other than the actual caesareans. I am happy and very fortunate 
to live, give birth and work in a developed country like Sweden.
1.1 Interventions
Worldwide, when addressing maternal health one has implemented strategies to 
reduce maternal mortality by focusing on the causes of pregnancy related deaths, 
increased skilled birth attendance, giving birth in facilities, and an access to basic 
maternal health care. These strategies has been partly successful, although mater-
nal mortality and morbidity has not decreased as rapidly as hoped. Still care is 
insufficient, this is in the literature referred to as “too little, too late”. The increase 
of births in facilities in some parts of the world has, on the other hand, led to an 
overuse of interventions and an over-medicalisation of birth, “too much, too soon”.1
2The aim of health care professionals in obstetrics is a healthy mother and infant 
and to avoid unnecessary interventions as well as to achieve a low frequency of 
morbidity and mortality. However, the frequency of caesarean deliveries (CDs) 
has increased over the last decades without any corresponding decrease in mor-
tality and morbidity.2
In low risk pregnancies and labour processes, emphasis has been put on women’s 
and clinician’s shared decisions for obstetric interventions that are both evidence-
based and patient-centred. The base for performing an intervention is the knowledge 
of its risks and benefits for both the woman and her child. It is often discussed and 
believed that one intervention leads to a “cascade” of further obstetric interven-
tions.3, 4 This cascade of interventions may start as early as when the woman is 
presented to the delivery ward, and the earlier the intervention begins the greater the 
probability of progress to other interventions with the cascade down to  caesarean 
delivery.4 It is of great importance to better understand this cascade to be able to 
reduce the caesarean delivery rates.4 
Both the induction of labour and the caesarean delivery are common interven-
tions in obstetric care. They are necessary but often overused1, and over the last 
decades have been steadily increasing in frequency.2, 5, 6 These two interventions 
go hand-in-hand, since many of the indications for either intervention often are 
the same or concatenated, approximately 20-40% of all inductions in first time 
mothers ends with a caesarean delivery.7-12 
32 INDUCTION OF LABOUR
2.1 Background
Labour induction is a common obstetrical intervention that has increased to up to 
20% of all deliveries in many developed countries. In Sweden, 18% of all single-
ton deliveries at term were induced in 2017 (Figure 2.1).
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Figure 2.1. Induction of labour, singleton at or beyond term. The National Board of Health 
and Welfare, the Swedish Medical Birth Register 1973–2017. *In 2017, 3000 births are 
missing from region Skåne.
The goal of the induction of labour is to achieve a vaginal delivery before the 
spontaneous onset of labour. Induction is generally looked upon as a therapeutic 
action when the risk of induction outweighs the risks of prolonging the preg-
nancy. The benefits of induction must be weighed against the potential maternal 
and fetal risks.13 Induction of labour has often the same indications as a caesarean 
delivery (CD); obstetric indications (e.g. postterm pregnancy, prelabour rupture 
of the membranes, choriamnionitis, preeclampsia or diabetes) but can also be per-
formed due to fetal indications (e.g. non-reassuring fetal monitoring, intrauterine 
growth restriction, oligo- or polyhydramniosis). Over the last decades, induction 
on maternal request has become more common.6, 14 
4The main clinical concern, and a subject for discussion over the world, is whether 
induction of labour increases the risk of CD, mostly due to failed induction or 
fetal distress caused by uterine hyperstimulation and prolonged delivery. There 
are studies suggesting that the induction of labour increases the risk of CD.7, 8, 11, 
15 Later studies comparing induction of labour with expectant management, as 
well as randomised studies, have come to other conclusions, as described below.
Prelabour rupture of the membranes
A Cochrane systematic review, comparing induction of labour and expectant 
management in women with prelabour rupture of the membranes at 37 weeks’ 
gestation or more, concluded that induction (with methods such as oxytocin or 
prostaglandin) reduces the risk of maternal infections without increasing CDs 
or operative vaginal births, and fewer infants went to neonatal intensive care.16 
A study by Hannah et al. comparing women randomly assigned for induction of 
labour or expectant management for prelabour rupture of the membranes at term 
found that women viewed induction more positively than expectant management 
and there was no significant difference in CD rates (10.1% CD in the induction 
group compared to 9.7% in the expectant management group, odds ratio (OR) 0.9; 
95% confidence interval (CI) 0.7-1.1) or neonatal infection between the groups.17
Gestational hypertension or mild preeclampsia
In the “HYPITAT” study, 756 women with gestational hypertension or mild 
 preeclampsia were randomised to either induction of labour or expectant manage-
ment, 31% and 44% respectively developed a composite of poor maternal outcomes 
as maternal mortality, maternal morbidity (eclampsia, HELLP syndrome, pulmo-
nary oedema, thromboembolic disease, and placental abruption), progression to 
severe disease, or major post-partum haemorrhage, (relative risk (RR) 0.71, 95% 
CI 0.59-0.86, p<0.0001). In absolute numbers rates of CDs were higher in the 
expectant management group, although it was a non-significant difference (14% 
vs 19%, RR 0.75, 95% CI 0.55-1.04, p=0.085).18
Maternal request
Induction of labour on maternal request/ without medical indication is debated 
and has shown contradictory results. A large retrospective study from Scotland, 
comparing induction on maternal request with women continuing pregnancy to 
either spontaneous labour, induction of labour or CD at a later gestation, concluded 
that elective induction at term can reduce perinatal mortality without increasing 
the risk of operative delivery.19 However, in a study from New York State, with a 
similar design as the Scottish study, an association of an increased risk of CD after 
induction of labour on maternal request was found.8 A meta-analysis by Mishanina 
et al. published 2014, concluded that their “analysis provides a robust answer to 
5the disputed question of risk of CD associated with induction of labour”. Women 
whose labour was induced were less likely than those managed expectantly to 
have a CD.20 Recently, a randomised study by Grobman et al. randomised low-
risk nulliparous women to either labour induction in gestational week 39+0 to 
39+4 or expectant management with delivery induced, if needed, at earliest 40+5 
weeks and no later than 42+2 weeks. The conclusion was that induction in the 39th 
week did not result in a lower frequency of adverse composite neonatal outcome, 
although it did result in a lower frequency of CDs (18.6% vs. 22.2%; RR 0.84; 
95% CI 0.76-0.93).21
Postterm pregnancy
There are randomised studies showing that there is an association of increased risk 
of maternal and fetal adverse outcomes at late term pregnancy in comparison with 
term pregnancy. A Cochrane review including 30 randomised controlled  trials that 
studied women at or beyond term where the women either had a labour induc-
tion or were treated with a policy of expectant management.22 They found that a 
policy of labour induction was associated with fewer perinatal deaths (RR 0.33, 
95% CI 0.14-0.78) and fewer CDs (RR 0.92, 95% CI 0.85-0.99) and a marginal 
increase in operative vaginal deliveries (RR 1.07, 95% CI 0.99-1.16). Most  studies 
had a policy of induction at 41 weeks in the intervention arm. The conclusion was 
that the absolute risk of perinatal death was small and that the optimal timing of 
induction of labour warrants further investigation.22 
In a multicentre randomised study from the Netherlands, they compared induction 
in gestational week 41 with expectant management and induction in gestational 
week 42.23 A significant difference of 1.4% was found for the risk of adverse 
perinatal outcomes when management was expectant, but the chances of a good 
perinatal outcome were high with both managements. There were no significant 
difference in composite adverse maternal outcomes or in CD rate.23 
A Swedish multicentre register based randomised controlled trial, SWEPIS,  compares 
induction of labour at 41 completed gestational weeks with expectant manage-
ment and induction at 42 completed gestational weeks. Their primary outcome is 
a composite of stillbirth, neonatal mortality and severe neonatal morbidity.24 This 
study is still under analysis and no final results has yet been presented at the time 
of writing this thesis.
Fetal macrosomia
In a Cochrane analysis from 2016 reviewing whether to induce labour in women 
with suspected fetal macrosomia it was concluded that the induction of labour did 
not significantly increase CD rates, but that the incidence of shoulder dystocia 
and infant fracture was significantly lower in the group were labour was induced. 
6This review was based on four trials with 1190 women, of which the largest trial 
included 822 women who were randomised to induction between 37+0 and 38+6 
gestational weeks or expectant management, with a mean birthweight of 3831 g 
in the induction group. The conclusion from reviewers was that more randomised 
studies are needed.25, 26 In another review of same four trials, by Magro-Malosso 
et al., they concluded that it may be reasonable to induce women for suspected 
fetal macrosomia, since the CD rates were the same in the induction group as in 
the expectant management group, even though there was no difference in the rates 
of shoulder dystocia, intracranial haemorrhage or brachial plexus palsy.27 There 
were two limitations with the largest randomised trial included in this review by 
Magro-Malosso et al.; the women from the largest trial represented almost 70% 
of all patients. Moreover, there were also diabetic women included in the study, 
introducing a bias of diabetes with its concomitant risk for shoulder dystocia. In 
the meta-analysis a significant reduction of fractures was found.27 In a comment, 
published in BJOG 2016, Norwitz states that these fractures must refer to clav-
icular fractures and that the diagnosis of them is often inaccurate, and if correctly 
diagnosed, the prognosis is benign with no sequelae.28 Recently, in a nationwide 
population-based Swedish cohort study by Moldeus et al. they compared non-
diabetic women with large for gestational age infants (>90th centile) induced at 38 
completed gestational weeks with expectant management. Women in the expectant 
management group delivered after 39, 40, 41 or 42 completed gestational weeks, 
either by labour induction or spontaneous onset of labour. This study had the oppo-
site results, emphasising the need for more studies. Women induced at week 38 
had a significantly increased risk of CD (aOR 1.44, 95% CI 1.20-1.72) compared 
with expectant management. There was no difference in 5-minute Apgar<7 or 
infant birth injury. Similar results was seen when comparing induction of labour 
at week 39, 40, 41 compared to expectant management.29
Other complications with induction of labour in general, include prolonged labour 
with complications such as increased postpartum haemorrhage, chorionamnionitis 
and admission to the neonatal intensive care unit.30
In summary, it is convincingly shown that induction of labour due to prelabour 
rupture of the membranes, hypertensive disease during pregnancy or on maternal 
request (no medical indication) is not associated with an increased risk of CD when 
compared to women with an expectant management. But weather to induce labour 
due to suspect fetal macrosomia or not, or when to induce a postterm woman, is 
not yet sufficiently studied.16-21, 25
2.2 Bishop Score
Cervical ripening is an important part of parturition, and includes remodelling 
through collagen breakdown, rearrangement and change of glucosaminoglycans, 
7increased production of cytokines and infiltration of the white blood cells.31 When 
inducing labour, the degree of ripening of cervix will guide the choice of method. 
To be as objective as possible in assessing the cervix, the modified Bishop Score 
is most commonly used where the cervical position, consistency, effacement and 
dilation are assessed and the engagement in pelvis of the presenting part is also 
assessed, giving points between 0 and 10 (Table 2.1).32, 33 An unfavourable cervix 
has been defined as a Bishop Score of 6 or less in most studies.13
Table 2.1. Modified Bishop Score
Points 0 1 2
Engagement of the 
 presenting part
above/at 
pelvis-entrance
above spinae at/below spinae
Cervical position posterior mid anterior
Cervical consistency firm intermediate soft
Cervical effacement none ≤ 50 % > 50 %
Cervical dilation ≤ 0.5 cm > 0.5 - ≤ 1.5 cm > 1.5 cm
2.3 Methods for induction of labour
Prostaglandin and intracervical balloon catheter
The most common medical cervical ripening methods are the synthetic prosta-
glandin E1 (PGE1) and prostaglandin E2 (PGE2). An advantage of using prosta-
glandins for induction of labour is their efficiency when the cervix is unripe. The 
efficiency is a result of the pharmacological synergism between cervix ripening 
and stimulation of the myometrium. A disadvantage of prostaglandins is the risk 
of uterine hyperstimulation, which may be a risk factor for the development of 
fetal hypoxia.34
Misoprostol (a synthetic PGE1-analogue) can be administered either vaginally, 
orally or sublingually. The studied doses of misoprostol are mainly 25 or 50 
micrograms (µg) for the induction of labour. There are many published studies 
and clinical experiences that support the safety and efficacy of misoprostol when 
it is used appropriately. The adverse maternal and fetal outcomes that has been 
reported in different studies results from using doses above 25 µg. An overdose 
may lead to hyperstimulation of the uterus and the accompanying fetal distress.34 
Cervical ripening with PGE2 is, according to RCOG guidelines from 2008, the 
golden standard.14 There are two frequently used and available PGE2 forms in 
Sweden; dinoprostone vaginal gel (2 mg or 1 mg) or dinoprostone vaginally 
applied pessary (10 mg).
8In a Cochrane review comparing oral misoprostol versus placebo/vaginal mis-
oprostol/dinoprostone or oxytocin, the conclusion was clear: “Oral misoprostol as 
an induction agent is effective at achieving vaginal birth. It is more effective than 
placebo, as effective as vaginal misoprostol and results in fewer caesarean deliv-
eries compared to vaginal dinoprostone or oxytocin”. And they further concluded 
“If using oral misoprostol, the evidence suggests that the dose should be 20 to 
25 µg in solution. Given that safety is the primary concern, the evidence supports 
the use of oral regimens over vaginal regimens” (Table 2.2).13, 14, 34
Mechanical methods used for inducing labour were the first methods developed for 
ripening the cervix. Laminaria tents, made of sterile sea-weed or synthetic hydro-
philic materials, introduced into the cervical canal, which enlarge the canal due to 
their hydrophilic properties.35 A common method is a balloon catheter introduced 
through the cervical canal, eventually into the extra-amniotic space, inflated with 
fluid and then applied with traction. The ripening is mediated by the mechanical 
dilation of the cervical canal and through an indirect increasing of prostaglandin 
or oxytocin secretion. The balloon catheter may also stimulate the neuroendocrine 
reflexes and thereby the onset of contractions.13
In a Cochrane review published in 2012, the conclusion was that mechanical 
methods had similar CD rates as prostaglandins, but a lower risk of hyperstimu-
lation of the uterus.36 This was also confirmed in two later randomised studies 
by Penell et al.10 and the PROBAAT-I study by Jozwiak et al.37 Further, in the 
Cochrane analysis, the proportion of multiparous women induced mechanically 
who had not delivered vaginally within 24 h was higher compared with inducing 
with vaginal dinoprostone. Compared with oxytocin, the mechanical methods had 
a reduced risk of CD.36 The PROBAAT-I study reported that dinoprostone had a 
shorter median time from start of induction to delivery, but this difference was 
only seen in the first 36 h.37
In the PROBAAT-II study by Eikelder et al. induction with misoprostol compared 
with balloon catheter was shown to result in a larger proportion of women delivered 
within the first 24 h, but after 36 h a larger proportion of women had delivered in 
the balloon catheter group.38 A study by Prager et al.9 comparing dinoprostone, 
vaginal misoprostol and balloon catheter showed on the contrary that balloon 
catheter induction led to a time-to-delivery that was about four hours shorter than 
the prostaglandin methods.9, 38 (Summary in Table 2.2.)
9Table 2.2. Summary of review or randomised studies comparing different induction methods
Type of 
study
Author, 
Journal, 
Year
Population Comparing Results
Syst. 
Review
Alfiervic et al. 
Cochrane 
201434
76 RCTs 
(14412 
women)
Oral misoprostol 
versus placebo/ 
vaginal dinoprostone/ 
vaginal misoprostol/ 
oxytocin
Oral misoprostol is  effective 
at achieving  vaginal birth. It is 
more effective than  placebo, 
as effective as  vaginal 
 misoprostol and results in 
fewer CDs than vaginal 
 dinoprostone or oxytocin.
Syst. 
Review
Jozwiak et al. 
Cochrane 
201236
71 RCTs 
(9722 
women)
Mechanical methods 
versus no treatment/ 
vaginal dinoprostone/ 
misoprostol/oxytocin
Mechanical methods result 
in similar CD rates but less 
 hyperstimulation compared 
to prostaglandins. Proportion 
of multiparous women not 
 delivered vaginally within 
24 h was higher compared 
with  vaginal dinoprostone. 
Compared to oxytocin, 
reduced risk of CD.
RCT Prager et al. 
BJOG 20089
592  
women
Balloon  catheter 
 versus  vaginal 
misoprostol/ 
dinoprostone
Balloon catheter: Shortest 
time-to-delivery (- 4 h). No 
 differences in  neonatal and 
maternal outcome. Prosta-
glandins had the same effect.
RCT Pennell et al. 
BJOG 200910
330 
nulliparas
Double balloon cath-
eter versus single 
balloon catheter/ 
dinoprostone gel
No differences in CD rates. 
Time-to-delivery longer in 
 double balloon group. PGE2 
group: More uterine hyper-
stimulation and worse cord 
blood samples. Less pain in 
single balloon group.
RCT PROBAAT-I 
Jozwiak et al. 
Lancet 201137
824  
women
Dinoprostone versus 
balloon catheter
Balloon catheter: Fewer CDs 
due to suspected fetal distress. 
Less treatment with intrapartal 
antibiotics. Longer time-to-
delivery, more oxytocin. Fewer 
to neonatal ward.
No difference in CD and 
operative vaginal delivery 
rates.
RCT PROBAAT-II 
Eikelder et al. 
Lancet 201638
1859  
women
Oral misoprostol (50 
µg/4h) versus balloon 
catheter
No difference in CD rate. More 
vaginal operative deliveries in 
 misoprostol group (RR 1.45). 
No  differences in maternal and 
 neonatal outcome.
More women had delivered 
in misoprostol group within 
24 h, but after 48 h more had 
 delivered in balloon group.
10
Two-step induction or sequential induction, refers to a mechanical method used after 
prostaglandin or vice versa, initiated if the first method did not have a sufficient 
effect on cervix ripening. This is often used, but not well studied and therefore 
making it difficult to reach conclusions.
Recently, in a randomised controlled trial comparing a mechanical method (double-
balloon) used simultaneous with either misoprostol 50 µg orally taken or placebo, 
resulted in no difference in CD rates, but time-to-delivery was significantly shorter 
when using both methods (14.6±6.9 versus 20.8±13.8 hours, p<0.0001) and use 
of oxytocin was significantly less frequent (86.9 versus 98%, p=0.01).39 
Other methods
Amniotomy or artificial rupture of the membranes may be used as an induction 
method in women who have a more favourable cervical ripening (Bishop Score 
≥6). But it is also used as the next step of induction in women after ripening of 
the cervix. Then amniotomy is often followed by the use of oxytocin. The evi-
dence for amniotomy alone as an induction method is insufficient. However, in 
a study of amniotomy combined with early oxytocin infusion, time-to-delivery 
was shorter than with amniotomy alone.40 This was later confirmed in a Cochrane 
review, where fewer women with amniotomy and oxytocin intravenous had not 
delivered vaginally after 24 hours than those with amniotomy alone (RR 0.03 
95% CI 0.0001-0.49).41
Oxytocin stimulates labour in a way similar to spontaneous labour, but patients 
can vary in their response to the drug. This is partly dependent on gestational age, 
with an increase in response from 20 to 30 gestational weeks. After 30 gestational 
weeks there is a plateau in the response and at term, sensitivity increases again.13, 42 
Cervical dilation, parity, gestational age and body mass index are factors influenc-
ing the response to oxytocin. With oxytocin-infusion, the uterus normally responds 
within 3 to 5 minutes and steady-state levels are reached within 40 minutes.13, 42
Membrane sweeping is a simple method that even can be performed outside the 
hospital. The health provider introduces a finger into the endocervical os and the 
inferior pole of the membranes are detached from the lower uterine segment by 
sweeping the examining finger in a circular movement. This can initiate prosta-
glandin production and the onset of labour. It may be accompanied by discomfort 
during the vaginal examination, and bleeding and irregular contractions later on. In a 
Cochrane review it was concluded that membrane sweeping increases the likelihood 
of spontaneous onset of labour and reduces the frequency of pregnancies beyond 
41 gestational weeks. There was no difference in CD rates in comparison with no 
treatment. The number needed to treat to avoid one induction of labour was 8.43
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Nipple stimulation is a nonmedical, natural method for inducing labour, and in a 
systematic review, compared with no intervention there was a significant decrease 
in the number of women not being in labour within 72 h. However, this was seen 
only in women with a riper cervix. It was also associated with lower postpartum 
hemorrhage.13
Sexual intercourse as an induction method is very poorly studied. Only one study 
with 28 women was included in a Cochrane review from 2001. Human semen 
contains prostaglandin, but the role of sexual intercourse is not clear. It could be 
a result of the stimulation of the lower uterine segment or the endogenous oxy-
tocin that is released during an orgasm. The conclusion was, however, that this 
is an important issue to the woman and her partner and that further randomised 
studies are needed.44
Acupuncture or acupressure is used during labour for stimulating contractions and 
as a pain relief. The hypothesis is that the neurogenic stimulation increases the 
contractions of the uterus and acts as an induction method. A Cochrane review 
from 2017 showed no clear benefit of acupuncture or acupressure.45
Mifepristone (an anti-progesterone) is not very well studied as an induction method, 
although in a Cochrane analysis from 2009 it was shown that it is better than 
placebo in reducing the CDs performed due to failed induction of labour, but the 
effects on the infant have not been studied in any depth. More studies are needed 
before using mifepristone as an induction agent in the clinics.46
Although there are many studies on labour induction methods, it is still not convinc-
ingly shown which method is safest and most effective in nulliparous women with 
an unripe cervix with respect to the length of labour, mode-of-delivery, maternal 
and neonatal outcomes.
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3 THE FIRST CAESAREAN
3.1 History of caesarean delivery
Julius Caesar is said to have been born (100 B.C.) through a caesarean procedure, 
although, this is unlikely since his mother was said to live as he invaded Britain. 
According to a Roman law “Lex Regia”, already around 700 B.C., women dying 
or already dead through childbirth should be cut open in an attempt to save the 
life of the child, and the law forbade the burial of a pregnant woman before the 
child had been extracted from the womb. When Ancient Rome became the Roman 
Empire they changed the name of the law from “Lex Regia” to “Lex Cesarea”.47 
Other explanations for the name Caesarean could be the Latin word “caedare” 
which means to cut. 
One of the first written reports, from year 1500, is of a woman and child surviv-
ing a caesarean procedure, performed by Jacob Nufer, a Swiss sow-gelder (a 
person who sterilise female pigs), on his own wife after several days of labour. 
However, this is not fully accepted as true since this was first reported in 1581. 
In 1581 Francois Rousset published a work describing the caesarean method and 
also reasons for performing the caesarean section; large fetus, malformated fetus, 
dead fetus, twins, malpresentation.47
The first caesarean delivery in Sweden was performed 1758 by Schützer, a surgeon 
who was the queen’s chief physician. However in the 13 caesareans performed 
between 1758 and 1875, all women died. The operations were performed on women 
who had been in labour for several days. Later in 1875, there are descriptions of 
24 women undergoing caesarean deliveries under better surgical conditions with 
a survival rate of 75%. An important development in increasing maternal safety 
and reducing death was the introduction of suturing the uterus, first introduced by 
Lebas in 1769, later Max Sanger insisted on this in 1882.47, 48
In the late 19th century and beginning of the 20th century in U.S. and Europe, labour 
was moved into hospitals for women living in the cities. Obstetricians argued 
for earlier caesarean deliveries when labour was protracted, and more women 
had the chance to have a caesarean when needed as it became safer. In addition 
the availability of safe anaesthesia and antibiotics decreased the maternal and 
infant perinatal mortality rates.48 In Sweden between 1951 and 1955 the maternal 
mortality rate decreased to 0.5% when blood transfusions, parenteral infusions, 
uterotonic drugs, thrombosis prophylactics and antibiotics became a part of rou-
tine obstetrical care.49, 50 
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3.2 Rates of caesarean deliveries
In 1985 the World Health Organisation (WHO) recommended a caesarean  delivery 
rate of 10-15%. In a later document from 2015, WHO stated that CD rates above 
10% of a population level are not associated with a reduction in  maternal and new-
born mortality rates. As CD rates increased above 10% and even up to 30%, no 
further positive effect on maternal and neonatal mortality was seen (Figure 3.1). 
Effects on stillbirth and morbidity rates could not be assessed due to lack of data 
at the population level. But WHO also concluded that CD should be provided to 
women who needs this rather than to strive for specific rates.2 
Figure 3.1. WHO report Gibbons et al. 2010
From 1990 to 2006, the rate of CDs overall in Sweden rose from 11% to 18%,49 
and has been stable since then with today’s rate of 19% (Figure 3.2).6, 12 The rise 
in CD rates has partly been explained by changes in obstetrical care, for example, 
today 94% of women with breech presentation deliver with CD. High maternal 
age, high body mass index (BMI) and nulliparity are considered risk factors for 
CD, and as maternal age and BMI have both increased during the last decades, 
this might have contributed to the high CD rates. In a report by the Swedish 
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Medical Birth Register from 2005, it is shown that CDs on maternal request has 
increased, however these deliveries only constitute 4.6% of all CDs (9.7% of all 
elective CDs).5, 6, 49
Caesarean deliveries 1973-2017
Percent
Ref: Medical Birth Register, Swedish National Board of Health and Welfare
All caesareans Unplanned caesareans Planned caesareans
Figure 3.2. Rate of caesarean deliveries 1973-2017, The Swedish Medical Birth Register 
Dark grey line: All CDs, Light grey line: Planned CDs, Dotted line: Unplanned CDs
In the U.S the CD rate increased from 5% to more than 31% between 1970 and 
2007, as a result of several changes in obstetrical practice; the introduction of 
electronic fetal monitoring, decreased amount of breech vaginal deliveries and 
forceps deliveries. It was also an opinion flourishing, that “once a caesarean 
always a caesarean”.51 However, changing the attitude of once a caesarean always 
a repeat caesarean, increased rates of vaginal births after caesarean, and this led 
to decreased CD rates (20%) in 1996. Later when more women underwent trial 
of labour after caesarean (TOLAC), the frequencies of uterine rupture and other 
complications increased, resulting in today’s caesarean rates of 32%. In 2002 
only 12.7% of women in U.S. with one previous CD had a vaginal delivery in 
subsequent pregnancy.52-54
There has been a lack of consistency when comparing CD rates regarding  women’s 
obstetrical history, and there was no international classification system that would 
facilitate comparison between countries and regions. After being thoroughly 
reviewed by experts, a classification system based on the women’s obstetric char-
acteristics, by Dr Michael Robson in 2001, was proposed by WHO to be used 
from 2014 as an international system to classify pregnant women admitted for 
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delivery.2, 55, 56 This classification system stratifies women exclusively into ten dif-
ferent groups based on parity, onset of labour, gestational age, fetal presentation 
and number of fetuses and thereby facilitates comparison of CD rates with fewer 
confounding factors (Figure 3.3).55
Figure 3.3. Robson Classification, WHO
16
3.3 Indications of caesarean delivery
Another way to compare CD rates, and to better understand the underlying  reasons 
for performing a CD is to study the indications for the CDs. The different reasons 
could either be due to elective, planned indications or unplanned, emergency 
indications.5, 49
3.3.1 Unplanned indications
Labour dystocia
Labour dystocia, or arrest of labour, is the main cause of primary unplanned CD 
and also contributes to a great number of repeat CDs.5, 57 Labour dystocia can 
be diagnosed in the active phase of first stage or in the second stage of labour.58 
Dystocia is reported to have an increasing incidence and this could be due to several 
factors: increasing maternal age and overweight; fetal macrosomia; but also due 
to change in obstetrical practice over time with more use of oxytocin and epidural 
analgesia; fewer instrumental vaginal deliveries; and of great importance, there is 
a lack of consensus in definition of the normal labour progress.58, 59 About 12% of 
women with previous dystocia have a recurrence, and in women with a previous 
CD due to dystocia the recurrence rate is 34%.60 A prolonged delivery is associ-
ated with risks for both the mother (haemorrhage, chorioamnionitis, endometritis 
and lacerations) and infant (birth asphyxia, meconium aspiration and shoulder 
dystocia).54, 58, 61 However, dystocia is a complex condition and complex to study 
due to many associated diagnostic codes, and there is also no consensus on a pre-
cise definition when the active phase of the first stage of labour begins and how 
a normal labour progress is defined. In 2014, the American College of Obstetrics 
and Gynaecology defined the start of the active phase as when cervical dilation 
is 6 cm.62, 63 However, in the NICE guidelines from 2014, the Royal College in 
the United Kingdom defined the start of labour as when the woman has regular, 
painful contractions and a progressive cervical dilation from 4 cm.64, 65 In 2001, 
Sweden defined active labour as when the woman fulfilled two of three criteria; 
cervical dilation of 3-4 cm, three or more regular contractions every ten minutes, 
rupture of the amniotic membranes.66 
The second stage of labour begins when the cervix is fully dilated and ends with the 
delivery of the infant. Parity, use of epidural analgesia, delayed pushing, maternal 
BMI, birth weight, and occiput posterior position of infant all have the  possibility 
to affect the length of the second stage. To define an appropriate duration of the 
second stage is complicated, the short- and long-term maternal and neonatal out-
comes must be considered. There are studies of nulliparous women concluding 
that a longer duration of active pushing, >3-4 hours, is not associated with adverse 
neonatal outcomes.67, 68 However, in multiparous women, pushing for >3 hours 
is associated with an increased risk of neonatal morbidity (5-minute Apgar score 
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of <7, admission to the neonatal intensive care unit, and a composite of neonatal 
morbidity).69 A longer second stage of delivery is associated with adverse maternal 
outcomes; higher rates of third- or fourth degree perineal lacerations, postpartum 
haemorrhage and infections.70 Thereto the probability of reaching a vaginal delivery 
is decreasing with every hour of the second stage.70 Still there is no clear cut off how 
long the duration of second stage may be.64 Recently a consortium for preventing 
the primary CD in the U.S. and WHO, both recommending, when maternal and 
neonatal conditions permit, at least 2 hours of second stage in multiparous women 
and 3 hours in nulliparous women, before interrupting for operative delivery.64, 71 
In 2018, WHO published definitions of the different stages in labour in an attempt 
to harmonise these definitions and decrease CD rates due to dystocia.71
Failed induction of labour
Failed induction of labour, also a common indication for CD where, despite many 
hours of induction with prostaglandins and/ or mechanical methods, or even many 
hours of an oxytocin infusion, the woman does not establish, or proceed, in the 
active phase of labour. There is a lack of consistency in guidelines; when to termi-
nate an induction and proceed with a CD and most likely a variation in practice. 
Recommendations today, suggest allowing longer durations of the latent phase 
( ≥24 hours) and longer time of administrations with oxytocin (at least 12-18 hours) 
before stating a failed induction.64
Fetal compromise
At the beginning of the 1900s, fetal monitoring during labour was performed through 
auscultation, for example with Pinard’s horn. During the 1950s the technique of 
electronic fetal surveillance was developed. In the 1970s cardiotocography (CTG) 
was introduced in Sweden and became widely used in the latter part of the twentieth 
century to decrease the perinatal mortality.49 A Cochrane meta-analysis of thirteen 
existing randomised trials stated that compared to intermittent auscultation, the 
use of CTG during labour was associated with halving the number of neonatal 
seizures and led to a significant increase in caesarean deliveries, but resulted in 
no differences in the rate of cerebral palsy or overall perinatal mortality. On the 
other hand, a meta-analysis from 1995, which excluded deaths not attributed to 
fetal hypoxia, reported a significant reduction in perinatal mortality.72, 73 CTG is 
used as a standard fetal surveillance in most of the labour wards in developed 
countries today. One of the most common indications for unplanned CD is fetal 
compromise, including non-reassured fetal well-being, placental abruption, uterine 
rupture and umbilical cord prolapse.5, 57 In an analysis of indications for CD over 
time, in Sweden between 1995 and 2006, fetal indication accounted for 12% of 
the increase of CDs. 31.7% of women with a single infant, in cephalic presentation 
that was delivered by a caesarean at or beyond 37 gestational weeks, had a CD 
due to fetal indication. Almost 1/3 of all CDs with the indication labour dystocia 
also had an indication for non-reassured fetal well-being.5, 49
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3.3.2 Elective indications
Breech presentation
Since the 1970s the number of vaginal breech deliveries has decreased in devel-
oped countries. After a randomised, multicentre trial by Hannah et al. published 
in 2000 with the conclusion that perinatal mortality, neonatal mortality, or serious 
neonatal morbidity was significantly lower for the elective caesarean section group 
than for the planned vaginal birth group74, the number of vaginal breech deliveries 
dropped further. These results have recently been confirmed in a meta-analysis, 
where they found that the relative risk for adverse outcomes in the neonate was 
increased as in the study by Hannah et al., but the absolute risks were comparable 
with the absolute risks for giving birth vaginally to an infant in cephalic presenta-
tion. This resulted in the recommendation to make an individualised decision on 
the route of delivery in women bearing an infant in a term breech presentation.64, 75 
In Sweden 94% of infants in breech presentation are born by CD.5, 49, 76
Maternal request
Caesarean delivery on maternal request has become more prevalent lately. In a 
study from the Swedish Medical Birth Register, for all births in Sweden, between 
1996 and 2006, increased maternal age and increased BMI was the underlying 
cause of one third of the increased CD rates over the period.5 CD on maternal 
request contributed to 8.5% of the increased CD rates. However, the maternal 
request CD rate over the period studied was only 4.6% of all CDs.5, 49 There can 
be many underlying reasons for elective CD on maternal request, e.g. primary or 
secondary fear of delivery, sexual abuse, loss of trust for health care providers, 
anxiety or depression.77-79 In a Swedish study comparing indications for CD at 
Karolinska University hospital in Stockholm, 10.5% and 38.5% of elective CD 
indications were a result of maternal request in 1992 and 2005 respectively. Among 
these women 23% were nulliparous, 23% had had a previous vaginal delivery and 
54% had undergone a previous CD.80
Placenta praevia
Abnormal forms of placentation such as placenta praevia (placenta is lying over 
the endocervical os of the cervix), are managed with a CD. The incidence is about 
1 in 200 term pregnancies but varies throughout the world.81 The incidence is 
thought to have increased in relation with the increasing CD rates. In Sweden, 
placenta praevia appears in 0.3% of all deliveries.82 
Multiple infants
Both with term di- and monochoriotic twins, when the first twin is lying in cephalic 
presentation, vaginal delivery is internationally considered as the best option.83 
But when the first infant is not in cephalic presentation or the pregnancy is mono-
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amniotic or very preterm (gestational age below 32 weeks) CD is recommended. 
CD is also generally recommended in triple (or more infants) pregnancy due to 
problems with monitoring with conventional CTG.49, 84, 85
Intrauterine growth restriction and preterm births
Intrauterine growth restriction may be an indication of CD, especially when severe 
and/or fetal blood flow is pronouncedly affected as this predicts a great risk of 
intrapartal asphyxia.86 In cases where there is a risk of preterm birth, it has not 
been shown that CD brings any benefits if the only indication of CD is prema-
turity. However in Sweden there is a consensus that when the infant is in breech 
position, placental insufficiency is present or there are other fetal indications, CD 
is usually to be preferred.87, 88
Other fetal or maternal factors
Infants ≥4500 g are considered to be macrosomic and based on consensus and 
expert opinion, elective CD may be considered for suspected fetal macrosomia in 
cases of an estimated fetal weight >5000 g in pregnant woman without  diabetes 
and >4500 g in women with diabetes.64 CD should also be considered when a 
prolonged second stage of labour or an arrest of descent occurs in patients with 
an estimated fetal weight >4500 g. The clinical dilemma is that the diagnosis of 
macrosomia is imprecise and the prediction of shoulder dystocia is poor.64 Fetal 
malformations or fetal thrombocytopenia, as well as different infectious diseases 
in the mother (e.g. HIV, Hepatitis B and Herpes Simplex) are rare conditions and 
may be indications of CD.49, 64, 83, 89
Other possible indications for an elective first CD are tumours in the delivery 
channel that form obstacles for vaginal delivery, permanent cervical cerclage after 
trachelectomy, vasa previa or previous vaginal or incontinence surgery.
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Table 3.1. Summary CD rates by indication, and vaginal delivery rates in nulliparous 
women at or beyond term. The Stockholm-Gotland Obstetric database, 2008-2014
Nulliparous women, n = 76468  
Indication of CD n (% of all CDs / % of all deliveries)
Labour dystocia 3899 (24.5/5.10) Macrosomia 149 (0.9/0.19)
Non-reassuring fetal well-being 3714 (23.3/4.86) Placenta praevia 144 (0.9/0.19)
Breech presentation 2830 (17.8/3.70) Intrauterine growth 
restriction
141 (0.9/0.18)
Maternal request 2193 (13.8/2.87) Placental abruption 108 (0.7/0.14)
Induction failure 751 (4.7/0.98) Obstetric history 96 (0.6/0.13)
Other 538 (3.4/0.70) Pelvic disproportion 94 (0.6/0.12)
Abnormal presentation 410 (2.6/0.53) Previous uterine 
operation
93 (0.6/0.12)
Disproportion 339 (2.1/0.44) Prolapse of  
umbilical cord
40 (0.3/0.05)
Preeclampsia 196 (1.2/0.26) Diabetes 15 (0.1/0.02)
Missing indication 176 (1.1/0.23)
Total CD, n (%) 15926 (20.8)
Instrumental vaginal deliveries, n (%) 11175 (14.6)
Non-instrumental vaginal  deliveries, n (%) 49367 (64.6)
24%
23%
18%
14%
5%
11%
3%
2%
CD indicaon Labour dystocia
Non-reassuring fetal 
well-being
Breech presentaon
Maternal request
Inducon failure
*Other and indicaons <2.0%
Abnormal presentaon
Disproporon
Figure 3.4. Summary CD rates of all CDs by indication in nulliparous women at or 
beyond term. The Stockholm-Gotland Obstetric database, 2008-2014 
* Including, from Table 3.1: Other, preeclampsia, missing indications, macrosomia, 
placenta praevia, intrauterine growth restriction, placental abruption, obstetric history, 
pelvic disproportion, previous uterine operation, prolapse of umbilical cord, and diabetes
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3.4 Maternal risks with caesarean delivery
3.4.1 Short term risks
Birth complications are not rare in vaginal births but are more frequent in CDs. These 
complications can be minor or severe and can occur immediately (short term) or 
have long-term consequences. Studies consistently show that CD is associated with 
small but measurable increased maternal and neonatal risks when compared with 
vaginal delivery. These risks include infection, blood transfusion, injury, death of 
mother or infant, fetal asphyxia or developmental delay of infant, lower likelihood 
of breast-feeding and longer hospital stay.83, 90, 91 A large Canadian population-based 
study on composite severe maternal morbidity (defined as haemorrhage requiring 
hysterectomy or transfusion, uterine rupture, anaesthetic complications, shock, car-
diac arrest, acute renal failure, assisted ventilation, venous thromboembolic event, 
major infection, or in-hospital wound disruption or hematoma), studied morbidity 
and mortality in healthy women who underwent a planned CD due to breech pres-
entation of the infant.90 These women were compared to a similar group of women 
who had planned to deliver vaginally. The authors of the study reported that 2.7% 
(adjusted OR 3.1, 95% CI 3.0-3.3) of women experienced severe morbidity with 
planned CD compared to 0.9% with a planned vaginal delivery. Compared to planned 
vaginal delivery, the group with planned CD had increased risk of cardiac arrest 
(adjusted OR 5.1, 95% CI 4.1-6.3), wound hematoma (OR 5.1, 95% CI 4.6-5.5), 
hysterectomy (OR 3.2, 95% CI 2.2-4.8), major puerperal infection (OR 3.0, 95% 
CI 2.7-3.4), anaesthetic complications (OR 2.3, 95% CI 2.0-2.6), thromboembolism 
(OR 2.2, 95% CI 1.5-3.2) and haemorrhage requiring hysterectomy (OR 2.1, 95% 
CI 1.2-3.8). However, the increase of the absolute risks were small. The results 
were based on an intention-to-treat basis, the planned vaginal delivery group also 
included unplanned CDs and vaginal instrumental deliveries.90
The most serious complication after CD, which however, is very rare in developed 
countries, is maternal mortality. In confidential enquiries into maternal deaths 
from the United Kingdom in 2000-2002, the relative risk of maternal mortality after 
elective and unplanned CD were 2.8 and 4.3 respectively, compared with vaginal 
delivery.92 This result could reflect an association between underlying maternal mor-
bidity and the risk of death rather than the CD procedure itself. But many women 
who deliver vaginally have the same difficulties with an under lying morbidity.92, 93 
In the Canadian study mentioned above no mothers died in-hospital in the planned 
CD group, while in the planned vaginal delivery group 41 women died giving a 
mortality rate of 1.8 per 100 000 deliveries, though this is a non-significant dif-
ference (p=0.87).90 The leading causes of death in the U.S are thromboembolism, 
haemorrhage and hypertensive disease, whereas thromboembolism and haemorrhage 
occur more often in CD.91 It is hard to attribute the exact mortality risk of CD, but 
estimations suggest a 2-3 times higher risk of maternal death in elective CD and 4 
times greater risk in unplanned CD in comparison with vaginal delivery.91
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In the U.S., wound infections have, been reported to occur in 3% of CDs and 
may be increasing due to increasing prevalence of obesity. Severe anaesthetic 
complications (including problems with intubation, aspiration pneumonitis, drug 
reactions, and complications from high spinals) have a higher incidence in CD 
(0.29/1000 primary CD) compared to vaginal deliveries (0.06/1000 deliveries). 
The risk of death from general anaesthesia during CD has decreased over the past 
30 years in the U.S from 16.8 to 6.5 deaths per million. However, the risk of death 
attributed to general anaesthesia during CD is approximately twice as high as death 
 attributed to regional anesthesia.91
Compared with vaginal delivery, CD is associated with higher rates of postpartum 
haemorrhage (defined by WHO as ≥500 mL within 24 hours of birth, severe post-
partum haemorrhage ≥1000 mL94) and following risk of blood transfusion or hys-
terectomy. Hysterectomy is reported to occur in 0.2-5/1000 births and is associated 
with CD. The risk is 10-20-fold higher in CD compared with vaginal deliveries.91
Other surgical complications include bowel or bladder injury, postoperative ileus, 
amniotic fluid embolism, air embolism, thromboembolic disease and maternal 
death.91
However, a vaginal delivery is also not free from risks. Approximately 10% of 
all women delivering vaginally encounter some form of complication.90 Vaginal 
delivery is associated with increased risk of third- and fourth-degree perineal tears 
with its long term risk of faecal incontinence. Moreover, studies show that vaginal 
delivery is associated with an increased risk of urinary incontinence compared to 
CDs. But it is unclear if this association is explaining the long term persistence of 
incontinence, or if there are other factors (age, obesity, parity) that contribute to 
the dysfunction of the pelvic floor.91
3.4.2 Long term risks
Uterine rupture is a feared complication and appears mostly during labour in 
women who have previously had an operation performed on their uterus. After 
one  uncomplicated CD, the risk of rupture was in a study from U.S. 0.5-0.7% in 
a subsequent delivery.95 In a Swedish study by Hesselman et al., the uterine rup-
ture incidence was 1.3% in women performing a trial of labour after one previous 
CD.96 To avoid the risk of uterine rupture including the risk of maternal and neo-
natal mortality and morbidity, many clinicians and women in developed countries 
demand for a repeat CD.97 In the U.S, 92% of women with one previous CD have 
a repeat one.54 Hence, one of the greatest risks of a CD is a repeat CD. Risk factors 
for uterine rupture are more than one previous CD or CD with incision methods 
such as classical-, inverted T- or J-incision or other surgical procedures involving 
the endometrium (myomectomy).97 Generally, a planned CD is recommended in 
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these situations. Maternal characteristics increasing the risk for rupture are  obesity, 
age above 35 and an inter-delivery interval of less than 18 months.49, 54, 95, 97 
The risk of abnormal placentation (praevia and/or invasive placenta) increases with 
number of previous CDs. Invasive placenta with placenta accreta, increta and per-
creta is defined as the trophoblastic attachment, an invasion into the myometrium, 
invasion through the myometrium and serosa respectively. As seen in Figure 3.5 
the incidence of invasive placenta has been increasing as a result of the increas-
ing numbers of CDs over the last decades. Incidence of invasive placenta varies 
among different reports but the range is between 1 in 300-533 pregnancies in the 
U.S.81, 98 According to a Nordic study the incidence of invasive placenta so severe 
that the women had to have a laparotomy was 3-4 cases in 10,000 deliveries.82
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Figure 3.5. CD and Accreta incidence in U.S
A large multicentre cohort study has shown that the risk of invasive placenta 
increases with the number of previous CDs. The risk was even greater for women 
with placenta praevia and a previous CD. As shown in Figure 3.6, women with 
placenta praevia ran a 3%, 11%, 40%, 61% and 67% risk of invasive placentation 
at the first, second, third, fourth and fifth or more CDs, respectively. The rate of 
invasive placenta also increases with increasing CDs without placenta praevia.99
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Figure 3.6. Proportion of invasive placentation with or without placenta praevia and 
previous CD
Invasive placenta is associated with considerable maternal and fetal morbidity and 
mortality. The maternal complications are major massive haemorrhaging that can 
lead to coagulopathy, multi-organ failure, hysterectomy, thromboembolism and 
even death. The neonatal complications are mainly coupled with preterm birth. 
With invasive placenta, as with all placental complications, it is crucial to have 
a correct and accurate prenatal diagnosis. When invasive placenta has been cor-
rectly diagnosed, prenatal health care providers can plan for deliveries in a multi-
disciplinary way for individualised treatment. This usually involves a planned CD 
with hysterectomy.81, 98, 100
A CD is, as mentioned above, associated with increased risk of abnormal placen-
tation including placenta previa, but also a risk of placental abruption (ablatio), 
both of which potentially impact the health of the next infant. CD has also been 
associated with decreased subsequent fertility, increased likelihood of ectopic 
pregnancy or miscarriage. Increased complications during next pregnancy and 
labour including malpresentation, prolonged labour, emergency CD, uterine rup-
ture, preterm birth, low birth weight, small for gestational age and stillbirth have 
also been reported. However, neither is vaginal delivery without complications, 
but maternal and neonatal mortality is increased in caesarean that has followed 
labour, when compared with vaginal delivery or elective CD.91, 101
Finally, there is also a risk of abdominal adhesions after a CD. A Swedish study by 
Hesselmann et al. reported an increased incidence of adhesions after previous CD 
(37%) in women undergoing later abdominal surgery, compared to women with no 
previous CD (10%). Adhesions also increased with the number of CDs: 32% after 
one CD; 42% after two CDs; 59% after three or more CDs (p-value <0.001).102
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3.5 Neonatal risks with caesarean delivery
Caesarean delivery is associated with short-term risks such as asphyxia due to 
hypoperfusion of the uterus during conduction anaesthesia, scalpel lacerations 
and neonatal respiratory morbidity (from transient tachypnea of the newborn to 
severe respiratory distress syndrome) which require neonatal intensive care.91 
Studies suggest a gestational age-dependent incidence of neonatal respiratory 
morbidity in infants born by CD compared with vaginal birth103, and therefore 
since a  couple of years in many countries, it is recommended that elective CD is 
performed after 39 full gestational weeks. Labour also appears to have a protec-
tive effect on neonatal respiratory morbidity, as this morbidity is more present in 
infants born with CD before the onset of labour, compared with infants born with 
CD that has  followed labour (3.5% versus 1.2%; OR 2.9, 95% CI 1.9-4.4).91, 103 
CD is associated with altered stress response in the newborn infant. There are also 
studies stating that CD can have long-term immunologic implications on the infant 
and that the colonization of the gut flora is different in infants born by CD. Thereto 
longitudinal data that suggests that CD is associated with an increased incidence 
of asthma, food allergy and atopy and decreased rates of breast-feeding.49, 91, 103
Naturally there are also risks when being born by a vaginal delivery, this normally 
includes birth trauma such as shoulder dystocia and its concomitant sequela, 
asphyxia from delay in delivery, and injuries due to manipulations used to deliver 
the infant (i.e. brachial plexus injury). In a review from U.S., shoulder dystocia 
occurred in 0.2-2.0% of vaginal deliveries, and brachial plexus injuries occurred 
in 10-20% of all shoulder dystocia cases. Long-term sequela from brachial injuries 
occurred in 1-2 /10,000 births.91
26
4 TRIAL OF LABOUR AFTER CAESAREAN
4.1 Background
Today, a trial of labour after one caesarean (TOLAC) is recommended in many 
countries and considered safe for both the woman and infant. The purpose of this 
is to limit the escalating CD rates and associated maternal morbidity.52, 97, 104 In 
a multicenter study, Landon et al. compared maternal and perinatal outcomes in 
more than 30,000 women undergoing TOLAC (n=17,898) or having an elective 
repeat caesarean delivery (ERCD) (n=15,801) before onset of labour.95 Uterine 
rupture occurred in 124 (0.7%) women in the TOLAC group and hypoxic-ischemic 
encephalopathy occurred only in infants whose mother was in the TOLAC group. 
In the case of 7 of the 12 infants who were affected, this followed a uterine rupture 
and the figure included 2 neonatal deaths. The rate of endometritis (2.9% vs 1.8%) 
and blood transfusion (1.7% vs 1.0%) was higher in women undergoing TOLAC, 
however hysterectomy (0.2% vs 0.3%) and maternal death (0.02% vs 0.04%) did 
not differ significantly between the groups.95
A vaginal birth after a caesarean (VBAC) is associated with fewer complications 
compared with ERCD.52, 53, 97 However, a TOLAC which ends with a repeat CD 
entails higher risks for complications, as described above, than ERCD.52, 97, 105 
Women with a previous caesarean ought to be reviewed in the next pregnancy in 
order for any contraindications for a TOLAC (e.g. previous uterine rupture, type 
of previous uterine incision, previous uterine surgery, placenta praevia) to be 
recognised.97 Previous investigations show that the likelihood of VBAC ranges 
between 60 and 80% in different settings and is influenced by both demographic 
characteristics, such as maternal age, maternal body mass index and weight gain 
during pregnancy, maternal medical illness and obstetric history, such as indication 
for first caesarean.106, 107 In addition, studies have reported a relationship between 
cervical dilation in the first labour and VBAC rates. These relatively few previous 
studies are limited by study size, provide contradictory results, and may include 
multiparous women with previous vaginal and caesarean deliveries, making it 
difficult to assess the risk of repeat CD.108-116
A large study by Hoskins and Gomez found that women who were fully dilated 
at the first CD only had 13% success rate of VBAC in the subsequent delivery.108 
Furthermore, Kwon et al. reported that the degree of cervical dilation in women 
with previous labour dystocia did not affect the mode of delivery in a subsequent 
trial of labour.110 However, four other studies convincingly have shown that degree 
of cervical dilation in the first delivery does matter in the subsequent delivery, 
even when the indication for the first CD was labour dystocia (Table 4.1).109, 111, 
112, 116 Many of these studies include women with a previous vaginal and caesarean 
delivery, and since previous vaginal delivery is strongly associated with TOLAC 
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success117, interpretation and compare these with primiparous women may be 
difficult. Further, most previous studies are based on a single hospital or medical 
centre and local practices in TOLAC, and this is most likely to have affected the 
results and their generalisability. There is a lack of population-based studies with 
high granularity for maternal and obstetrical characteristics to further elucidate 
how obstetric historical factors influence the chance of successful TOLAC and 
to provide further knowledge when counselling women on safe birth after a first 
caesarean.
Table 4.1. Part of table 3 from Lewkowitz et al.112 Summary of previous studies on 
women performing TOLAC with previous CD due to labour dystocia. 
Reference Year Total study 
population,  
n
VBAC rate after 
prior CD for first 
stage dystocia,  
n (%)
VBAC rate after 
prior CD for 
second-stage 
dystocia, n (%)
Hoskins and Gomez108 1997 1,533 885/1,288 (69%) 32/245 (13%)
Bujold and Gauthier109 2001 859 429/654 (66%) 161/214 (75%)
Kwon et al110 2009 380 260/326 (80%) 41/54 (76%)
Abildgaard et al111 2013 355 100/115 (47%) 85/140 (61%)
Lewkowitz et al112 2015 238 59/132 (45%) 58/106 (55%)
Duff et al113 1988 131 78/114 (68%) 11/17 (65%)
Melamed et al a114 2013 93 — 57/93 (61%)
Ollendorf et al115 1988 88 37/53 (70%) 24/35 (69%)
Impey and O’Herlihy116 1988 40 16/25 (64%) 11/15 (73%)
a Only women with history of failed operative vaginal delivery who attempted TOLAC
4.2 Induction of labour after previous caesarean delivery
In the large multicentre study by Landon et al., with 33,699 women undergoing 
TOLAC, augmentation with oxytocin or the induction of labour were both asso-
ciated with increased risk of uterine rupture compared with spontaneous onset 
of labour (oxytocin only vs spontaneous onset: 1.1% vs 0.4%, OR 3.01 95% CI 
1.66-5.46, prostaglandin with or without oxytocin: 1.4% vs 0.4%, OR 3.95 95% 
CI 2.01-7.79, mechanical method with or without oxytocin: 0.9% vs 0.4%, OR 
2.48 95% CI 1.30-4.75).95 A sub-analysis of the same data only showed an increase 
of uterine rupture in induced women with no previous vaginal delivery (1.5% 
versus 0.8%, p-value=0.02), and the cervical ripeness at admission did not affect 
the uterine rupture risk.54 A dose effect could be seen as higher maximum doses 
of oxytocin resulted in an increasing risk of uterine rupture. In another sub-study 
of the same population, 67% of women with induced labour and 74% of those 
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requiring oxytocin augmentation achieved a vaginal birth compared to 81% of 
women with a spontaneous onset of labour (OR 0.50, 95% CI 0.45-0.55 and OR 
0.68, 95% CI 0.62-0.75, respectively).52, 95, 106
In a Cochrane review, West et al. conclude that the evidence for which induction 
method is to be preferred for women with previous CD is inadequate since studies 
are underpowered and the reported specific outcomes were scarce.118 In another 
Cochrane review concerning the choice between an ERCD and induced TOLAC, 
the conclusion was that both a repeat CD or induction are associated with both 
benefits and negative consequences. The evidence available today is from obser-
vational studies and should therefore be interpreted with caution. Randomised 
trials are needed to provide more reliable evidence.119
4.3 Childbirth experience
Giving birth to a child is an important event in a woman’s life. Most women recog-
nize that labour might be difficult in order to achieve a positive outcome for both 
themselves and the child. However, about 10% of women have a negative birth 
experience, which possibly affects both her and her family’s everyday lives and 
impairs bonding to the child.120 Sometimes the impact of a negative birth experi-
ence can be long-lasting and even impair future fertility.121-124 Birth experience 
is multidimensional and complex. However, known factors that are important 
and can affect the birth experience are maternal age, fear of childbirth, support 
from the midwife during delivery, lack of support from the partner, induction of 
labour, prolonged delivery and the memory of pain, expectations of giving birth, 
involvement and participation during labour, and surgical procedures.120, 125-131 The 
mode of delivery is also an important factor and affects the birth experience. For a 
first-time mother, having a non-instrumental, vaginal, delivery, is associated with 
the highest rated birth experience, whereas an unplanned CD is considered to be 
a worse birth experience.120, 125, 132, 133 
Knowledge about the woman’s birth experience in a subsequent delivery after a 
CD is scarce. The few previous studies show that after a counselling programme 
on mode of delivery for women with a previous CD, the birth experience was rated 
best in women achieving a VBAC.134-136 However, these studies were done after an 
intervention programme, were limited by confounding, had small or unrepresenta-
tive sampling, mixed parity and included women with a previous vaginal birth as 
well as premature births, and thereby had limited validity and  generalisability.134-136
4.4 Counselling women prior to delivery
Counselling pregnant women who had undergone a CD prior to their next delivery 
may be challenging and delicate. The woman and her health care provider must 
weigh the risks and benefits of attempting a TOLAC against having an ERCD. 
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The pregnant woman ought to be first reviewed before she is recommended to 
undergo a TOLAC. Due to enhanced risk of uterine rupture, one important criteria 
is that she has only one previous, low, transverse incision.95 Factors associated with 
increased risk for uterine rupture are lacking and prediction models to aid women 
and caregivers have not resulted in sufficient prediction accuracy.137
One of the most important known factors for successful TOLAC and achieving 
a vaginal delivery is a history of previous vaginal delivery.117 Other factors are 
that the indication for a previous CD was not labour dystocia, and at the trial of 
labour there was no need for induction or augmentation with oxytocin, and that 
there was a great cervical dilation at admission, a BMI of less than 30, Caucasian 
ethnicity and a young age.106 Previous studies claim that benefits of a TOLAC 
only exceed the risk of an ERCD when the probability of VBAC is greater than 
60-70%, depending also on the woman’s individual preferences.106, 137 Therefore, 
predicting the individual probability of VBAC could facilitate the decision-making 
for a safe birth.
A widely used model for predicting VBAC is developed by Grobman et al. and is 
based on multivariable logistic regression. It was developed to take into account 
factors present at the first antenatal visit in pregnancies after CD (maternal age, 
BMI, ethnicity, prior vaginal delivery, the occurrence of a VBAC, and a potentially 
recurrent indication for the CD).138 This model was further developed with even 
better prediction rates, taking into account both factors available at the woman’s 
first antenatal visit and factors that develop as the pregnancy proceeds (developing 
preeclampsia, cervical status at admission for delivery, BMI at or within 2 weeks 
of delivery and the undertaking of labour induction). The area under the receiver-
operating characteristics curve (AUROC) which is often used to compare tests for 
predicting, was 0.774 (95% CI 0.764-0.784) for this model. A fair test is said to 
have an area roughly between 0.70-0.80. An internal validation of the model by 
Grobman et al. showed the predicted probability of VBAC success corresponded 
closely with the actual probability for the women in the study.54, 138 Grobman’s 
model was modified and evaluated by Fagerberg et al. to suit a Swedish setting.139 
Both these models included women with previous vaginal delivery, which is one 
of the strongest predictors for VBAC.106, 117 There are, to my knowledge, no models 
primarily developed for predicting VBAC in women without a previous vaginal 
delivery, and whose delivery mode is more unpredictable for clinicians.
Today, the availability of data in health care is growing making it easier to use 
machine learning methods with their ability to consider many candidate predictors 
and which take into account complex relationships (non-linearity, other complex 
interactions) as prediction tools.140-144 These algorithms sometimes even includes 
predictors that clinicians might not have considered and the results may improve 
counselling if accuracy is high.145-148
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A study in 2014 by Kominiarek et al. which used a machine learning method 
based on classification and regression tree analysis (CART) showed that cervical 
dilation on admission followed by BMI, were the two most important variables 
for CD in nulliparas. The CART model makes a progressive dividing of the study 
population into subgroups according to the variables, and the mathematical model 
chose the strong predictive variables and tree-like order in which splitting occurs.147 
However, this hierarchial tree-building process can result in a model with low 
prediction accuracy, and therefore an improvement was developed by Breiman 
(2001), a “random forest” procedure. This procedure averages multiple regres-
sion trees, where from which the machine can detect and account for higher-order 
interactions as well as non-linear relationships. A disadvantage of this model can 
be difficulties in interpretation.149 
Yee et al. studied the relationship between the obstetrician’s cognitive and affec-
tive traits and the delivery outcomes among women eligible for TOLAC. They 
concluded that there was an increased likelihood of going into a TOLAC and suc-
ceeding with a VBAC if the obstetrician had more proactive strategy and displayed 
less anxiety.150 In another study they concluded that 83% of women with a previous 
CD had a preference for vaginal delivery and that they could accept a 59% risk of 
an unplanned repeat CD when undergoing TOLAC instead of choosing ERCD.151
Deciding whether to undergo a TOLAC or choose ERCD is complex and diffi-
cult and experiences after the first CD strongly influence the woman’s choice for 
next birth. Shorten et al. showed that for women that chose an ERCD, the risk 
with TOLAC and potential uterine rupture outweighed the desire of vaginal birth. 
Women who chose TOLAC seemed more confident in their body and valued vagi-
nal delivery for both the child and for themselves. After the delivery, both groups 
seemed satisfied with their choice but the women who chose TOLAC and then 
had to undergo a repeat CD were the least satisfied in comparison with women 
giving birth vaginally or by an ERCD. The health care providers and the health 
care system and culture in which the birth took place had strong impact on the 
woman’s choice.152
In a lifetime cost-effectiveness study in the U.S, Gilbert et al. studied the cost-
effectiveness of a TOLAC compared with ERCD, including long-term outcomes 
for both the mother and child, and used the results to determine the future health 
and economic consequences of the different delivery modes. The study team con-
cluded that when the probability of uterine rupture was 0.8%, TOLAC was less 
expensive and more effective than ERCD, as long as the probability of TOLAC 
success was 47% or more.153
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5 AIM
The overall aim of the project was to increase knowledge about delivery in women 
who had undergone one previous delivery, a caesarean. To study associations 
between subsequent modes of delivery with the indication of the first caesarean, 
the risk of a repeat caesarean and the risk of a negative birth experience. Thereto 
to develop machine learning models to predict vaginal birth after a previous 
 caesarean. Since indications for labour induction are strongly related to indications 
for caesarean delivery and about 20-40% of induced nulliparous women deliver 
by caesarean procedure, we also wanted to study the benefits and risks associated 
with different methods used for labour induction.
The specific aims were to:
• Study time-to-delivery and associated differences of risk (maternal and neo-
natal morbidity) with different methods for labour induction in nulliparous 
women with unripe cervix. (Study I)
• Study the risk of repeat caesarean delivery during a trial of labour after 
a caesarean in women with only one previous delivery. (Study II)
• Identify the association between delivery mode and the risk of a negative 
birth experience in women with only one previous delivery, a caesarean. 
(Study III)
• Develop new machine learning models and compare them with two earlier 
models used for predicting vaginal delivery in women with one previous 
delivery, who undergoes a trial of labour after caesarean. (Study IV)
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6 MATERIAL AND METHODS
6.1 Setting
All Swedish citizens, as well as people who have immigrated and have lived in 
Sweden for longer than one year have their own, unique personal identification 
number. This was introduced in 1947 and is used in the health care system, for 
medical records, school systems and for paying taxes. A newborn infant is given 
this personal identification number directly after birth.154 Together with the nation-
wide registers and the structure of the health care system, this, provides a unique 
possibility for epidemiological research.
All pregnant women have been offered free antenatal care in Sweden for over 
50 years now, and the insurance system does not influence the availability of 
this care. More than 98% of pregnant women participate in the antenatal care 
system and more than 99% of all births take place in hospitals. Normal pregnan-
cies and deliveries are taken care of by licenced midwifes with little involvement 
from obstetricians, while complicated pregnancies and deliveries are attended by 
obstetricians. Since the middle of 1980s almost all pregnant women are offered a 
routine ultrasound scan before the 20th gestational week to assess gestational age 
and multiple pregnancy as well as for screening for malformations. This ultrasound 
scan is performed on more than 97% of all women.12, 76
6.2 Data sources
6.2.1 The Stockholm-Gotland Obstetric Cohort
The population-based Stockholm-Gotland Obstetric Cohort155 includes all births 
between January 1st, 2008 and October 31st, 2014 at seven hospitals (n = 175,522) 
in the Counties of Stockholm (SLL) and Gotland. Some 25,000 to 30,000 deliv-
eries take place in the region each year, accounting for about 25% of all annual 
deliveries in Sweden. Pregnancy and delivery related data is forwarded from the 
electronic medical records system (Obstetrix, Cerner Inc., Stockholm, Sweden) 
used at all antenatal, ultrasound, delivery and postnatal care units in the region. 
Maternal and infant information for each pregnancy from prenatal care, delivery 
(including Bishop Score and partograph data) and the postpartum period are entered 
prospectively into the medical records by midwifes and physicians in a standard-
ised way. Detailed information about operative interventions, umbilical cord blood 
tests and examination of the new-born infant is included in the electronic medical 
record. This database was established at the Division of Clinical Epidemiology at 
Karolinska Institutet and funded by the Swedish Research Council.
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6.2.2 The Swedish Pregnancy Register
The Swedish Pregnancy Register began in 2013 and is a merge of the Swedish 
Maternal Health Care Register (established 1999) and the Prenatal Diagnosis 
Register (established 2010). Today the register covers 98.5% of all births in Sweden 
and has detailed information about antenatal care including ultrasound examina-
tions, delivery and postnatal care. Data from pregnant women are entered pro-
spectively into the electronic medical records on the first antenatal visit and every 
subsequent visit, ultrasound examination and at delivery and postnatal care. The 
Pregnancy Register facilitates improvement in the quality of care as a clinic can 
benchmark its performance over time, in comparison with other clinics, regions 
and the nation (Figure 6.1). Data from the Pregnancy Register is used for quality 
improvement, health care development and after ethical approval, may also be 
used for research. 156, 157
Figure 6.1. Example of “dash-board” view of all registered primiparous women in 
Sweden at or beyond term undergoing a TOLAC ending with a repeat CD, year 2018, 
The Swedish Pregnancy Register
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6.3 Study populations and study designs
6.3.1 Study I
Study I is a population-based cohort study with a study population from the 
Stockholm-Gotland Obstetric Cohort. This study comprised all nulliparous women 
with a singleton, live-born infant in cephalic presentation at or beyond 37 completed 
gestational weeks with induced labour. Women registered with more than one first 
induction method or with a Bishop Score 7 or more were excluded. Incomplete 
Bishop Scores were considered as missing.
The exposure in Study I was labour induction method; (a) prostaglandin E2 (dino-
prostone gel or vaginal pessary), (b) orally administered synthetic prostaglandin 
E1-analouge, misoprostol or (c) transcervical single balloon catheter. If more 
than one method was used we considered the first method of choice as exposure 
according to intention-to-treat.
Primary outcome of Study I was time-to-delivery, identified in the electronic 
labour records and defined as hours from the start of induction that is from the 
placement of the balloon catheter or the administration of the initial prostaglandin 
dose, to birth. Secondary outcomes were mode-of-delivery, maternal complica-
tions based on the International Classification of Diseases, 10th revision (ICD-10) 
defined as; (a) fever during delivery (temperature above 38.5 °C); (b) infections 
(including chorionamnionitis, endometritis, sepsis, urinary-, genital tract-and wound 
infection or other specified infections); (c) postpartum haemorrhage (estimated 
blood loss ≥1000 ml); (d) anal sphincter injury grade 3-4 (only vaginal births 
included) and (e) urinary retention (defined as >1000 ml at catheterization or post 
void residual bladder volume >300 ml). Neonatal outcomes included Apgar score 
of <4 or <7 at 5 min, metabolic acidosis defined as umbilical arterial pH <7.10 
and base excess (BE) < − 12 or only pH <7.0 and compound asphyxia (metabolic 
acidosis or Apgar <7 at 5 min).
6.3.2 Studies II and IV
Studies II and IV are population-based cohort studies with the study population 
from the Stockholm-Gotland Obstetric Cohort.155 We extracted information from 
the cohort on all women with a first and second singleton delivery during the study 
period between 2008 and 2014. We then selected all women with a second delivery 
with singleton, live-born infants in cephalic presentation at 37 or more completed 
gestational weeks who underwent a caesarean section at first delivery. All women 
who had an ERCD were excluded, thus only women undergoing TOLAC were 
included in the final study cohort (Figure 6.2).
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TOLAC (Trial of labour after caesarean) population
n= 3116
2nd delivery: elective repeat caesarean
n= 2186 (41.2%)
Women with 1st and 2nd delivery in the region, singleton in 2008-2014
n= 30 093
1st delivery: caesarean
2nd delivery: ≥37 gestational weeks, singleton, cephalic presentation, live born
n= 5302
TOLAC after previous elective 
caesarean
n=953 (30.6%)
TOLAC after previous unplanned 
caesarean
n=2163 (69.4%)
Figure 6.2. Flowchart of the population in study II and IV, women with first and second 
delivery between 2008 and 2014
Indication for first CD was the main exposure in Study II and was categorised 
into; 1) elective indication (reference) and 2) unplanned CD; a) labour dystocia, 
b) non-reassuring fetal well-being, c) other indications (e.g. preeclampsia and 
diabetes). Women, with a planned elective first CD, who came to the delivery 
ward with contractions or rupture of the membranes and whose vaginal cervi-
cal examination showed a cervical dilation greater than 2 cm, were categorised 
into “other indications”. Cervical dilation at the time of first CD in women with 
labour dystocia was categorised into: ≤5 cm, 6-10 cm and fully dilated. Women 
who underwent a first elective CD were assumed to have no cervical dilation at 
the time of the caesarean and were used as the reference category. In Study II the 
main outcome was risk of a repeated CD.
In Study IV, we studied the same population of women as in Study II, our aim 
was to predict vaginal birth in the second delivery in women with only one pre-
vious delivery, a caesarean delivery. We wanted to support clinical counselling 
before labour onset, so the temporal point of prediction was set between 35 and 38 
full gestational weeks. We included demographic and social variables from both 
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first and second pregnancies, variables related to the first pregnancy and CD, and 
information about first infant, pre-gestational health conditions, and conditions 
that developed during both pregnancies and information about each delivery hos-
pital. We also included sex of the second infant. Intended onset of labour was also 
included, since this is important for a successful TOLAC.106
We used three machine learning methods (conditional inference tree, conditional 
random forest, and lasso binary regression) to develop an individualised predic-
tion model. We compared the new models with two previously existing models by 
Grobman et al.158 and by Fagerberg et al.139, we measured area under the receiver-
operating curve (AUROC), overall accuracy, sensitivity, specificity and calibration.
6.3.3 Study III
Study III is a population-based cohort study with a study population from the 
Swedish Pregnancy Register.157 In this study, we collected information on all women 
registered in the Swedish Pregnancy Register with a first caesarean delivery and 
a subsequent birth of a singleton, live-born infant in cephalic presentation at 37 
or more completed gestational weeks during the years 2014-2017.
In many hospitals in Sweden, after delivery and before discharge from the delivery 
unit, women are asked about their childbirth experience. The visual analogue scale 
(VAS) scoring from 1 to 10, where 10 is a very positive and 1 is a very negative 
birth experience is used for this. The VAS scores are prospectively entered in the 
electronic medical records by the responsible midwife and forwarded into the 
Swedish Pregnancy Register. The preliminary analysis showed that some regions 
had lower rate of reporting birth experience, possibly due to differences in how the 
care was organized, although response rates did however increase over time. To 
diminish confounding resulting from organizational factors and to increase inter-
nal validity, we excluded women giving birth in hospitals with a birth experience 
response rate of less than 80% in 2017 (23 hospitals excluded). Until 2017, seven 
hospitals in the south-east region had the opposite interpretation of the VAS score, 
and we also excluded these hospitals. And finally, we excluded births where birth 
experience data was missing, giving us a final population of 780 women with a 
first and second birth in any of the remaining 12 hospitals (Figure 6.3).
The main exposure in Study III was mode of delivery for the 2nd birth, catego-
rised into elective repeat caesarean delivery (ERCD), vaginal birth after caesarean 
(VBAC) or unplanned repeat caesarean delivery (CD). Women with an ERCD 
were used as a reference. Further categorisation was made when studying 1st and 
2nd mode of delivery and its association with the outcome, 1st delivery was either 
elective CD or unplanned CD. Here women with an elective CD in both their 1st 
and 2nd births were used as reference.
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The main Outcome of Study III was the mean birth experience VAS score. 
Previous studies have shown that about 10% of women assessed their birth expe-
rience as negative.120, 159 In our study, 78 women (10% of 780) scored their birth 
experience as 5 or lower, and therefore a negative birth experience was defined 
as VAS score ≤5.
6.4 Statistical analyses
Maternal and delivery characteristics in Studies I, II and III were analysed using 
the Chi-square test for categorical variables and the Student’s t-test for continu-
ous variables. A two-sided p-value <0.05 was considered statistically significant.
In Study I, crude and adjusted mean time-to-delivery in hours with β-estimates 
and 95% confidence intervals (95% CI) was calculated by linear regression 
analysis adjusted for maternal age, height, BMI, year-of-delivery, delivery hos-
Figure 6.3. Flowchart of the population in study III
Women with 1st and 2nd singleton, live births at ≥37 gestational weeks
registered in the Swedish Pregnancy Register in 2014-2017
1st birth caesarean, 2nd birth eligible for trial of labour
n= 4328
Excluded: 
Women giving birth in 
hospitals with a birth 
experience response rate of 
<80% in 2017
n=3032
Excluded: 
Women giving birth in
SE region hospitals, due to 
reverse interpretation of the 
birth experience scale
n= 407
1st and 2nd birth in hospitals with a response rate of birth experience in 2nd birth of ≥ 80 % 
(year 2017)
n= 889
Excluded: 
Women with missing
birth experience in 2nd birth
n=109
Study population
n= 780
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pital, gestational age, hypertensive disease and diabetes (Model 1). In Model 2, 
adjustment for Bishop Score, was added as a continuous variable. Crude and 
adjusted odds ratios (aOR) with 95% CI were calculated using logistic regression 
to estimate the association between induction method and delivery within 24h, 
risk of caesarean delivery, instrumental vaginal delivery, maternal and neonatal 
complications with the dinoprostone group as a reference. In the adjusted logis-
tic regression model, we adjusted for the same confounders as in the final linear 
regression model (Model 2). Kaplan-Meier analyses, comparing crude time-to-
delivery, were calculated stratified by Bishop Score categories with delivery as the 
event. A Log-rank test was performed where a P-value of <0.05 was considered 
as statistically significant. We tested for interaction between induction methods 
and time to delivery by Bishop Score.
In Study II modified Poisson regression analysis was performed to calculate rela-
tive risks (RRs), with 95% confidence intervals (95% CI). Adjustments were made 
for the following confounders after they had been considered through a directed 
acyclic graph; maternal age, maternal height, body mass index (BMI), maternal 
pregestational diabetes and pregestational hypertensive disease at first pregnancy 
(Figure 6.4.). We performed stratified analyses for induction and spontaneous 
onset of labour and the risk of repeat CD. Finally, we investigated possible effect 
modification between the induction of second labour and the indication of a first 
CD associated with a repeat CD. A two-sided p-value <0.05 was considered sta-
tistically significant.
When analysing data in Study III, linear regression analysis was used to cal-
culate the β-estimates of mean birth experience and logistic regression used for 
analysing the odds ratio (OR) for negative birth experience. Both were used with 
95% confidence intervals (CI). Adjustments were performed for the following 
confounders; maternal age at 2nd birth, BMI, height, and cohabiting at first ante-
natal visit in the 2nd pregnancy, education (≤9 years of basic education, secondary 
school, university or college education), self-assessed health (categorised from 
very bad to very good) and fear of childbirth in the 2nd pregnancy (defined as hav-
ing the need of extra  support from either midwife, obstetrician or psychologist 
during pregnancy), and birth experience in the 1st birth (measured through the 
VAS score). Additionally, mode of delivery in 1st birth (elective or unplanned CD) 
was included as a confounder. Stratification by 1st birth, by 2nd mode of delivery 
with the analysis of mean birth experience and odds of negative birth experience 
was also performed. We also investigated a possible effect modification between 
mode of delivery in 1st and 2nd births associated with birth experience. A sensitivity 
analysis compared women giving birth in the hospitals included in our study with 
and without birth experience scores. A two-sided p-value of <0.05 was considered 
statistically significant.
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In Study IV, our general strategy was: 1) Curate the cohort to include all of the 
applicable variables used in Grobman138 and Fagerberg139 models. 2) Divide the 
cohort into training and validation sets, using a 1:1 split by random sampling. 
3) Replace missing data by using single imputation. 4) Predict VBAC in the vali-
dation dataset using the estimates reported by Grobman and Fagerberg. 5) Refit 
the logistic regression models by Grobman and Fagerberg in the training dataset 
and summarize their performance in the validation dataset. 6) Fit a conditional 
inference tree160, a conditional random forest161, and a lasso binary regression 
model using the training dataset and summarize their performance in the validation 
dataset.162 7) Compare the predictive performance of the new models with that of 
the Grobman and Fagerberg models. Then a sensitivity analysis was performed 
by fitting the same new models on the entire (training and validation) dataset and 
estimating classification error using 5-fold cross validation.144 For more detailed 
information, see Paper III. For all models, we calculated AUROC, accuracy, sen-
sitivity, and specificity in the validation dataset, based on a 50% decision cut-off 
for predicted probability. A calibration plot from the validation dataset for each 
model was constructed. This plot compares the predicted to observed probability 
of VBAC and provides a view of model performance across the range of predicted 
probability.
Analyses in Studies I, II and III were conducted by using SAS version 9.4. Study 
IV was analysed by using R version 3.5.1.
Figure 6.4. Directed acyclic graph (DAG) in study II. The influence of maternal character-
istics in 1st and 2nd pregnancy, and management in 2nd delivery, on the association between 
indication of 1st caesarean and risk of repeat caesarean delivery.
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Table 6.1. Summary of Studies I-IV
Study I Study II Study III Study IV
Design Cohort Cohort Cohort Cohort
Data source Stockholm-Gotland 
Obstetric Cohort 
2008-2014
Stockholm-Gotland 
Obstetric Cohort 
2008-2014
Swedish Pregnancy 
Register 
2014-2017
Stockholm-Gotland 
Obstetric Cohort 
2008-2014 
Population 7551 nulliparous 
women induced
3116 primiparous 
women undergoing 
TOLAC
780 primiparous 
women with a first 
CD and a subsequent 
delivery 
3116 primiparous 
women undergoing 
TOLAC 
Exposure Labour induction 
method:
1) dinoprostone 
2) misoprostol
3) single balloon 
catheter
Indication for first CD:
1) elective indication
2) labour dystocia
3) non-reassuring 
fetal well-being
4) other unplanned 
indications
Mode of 2nd delivery
1) ERCD
2) VBAC
3) unplanned 
repeat CD 
Prediction model:
1) by Grobman et al.
2) by Fagerberg et al.
3) Conditional 
 inference tree 
4) Conditional  
random forest
5) Lasso binary 
regression
Outcome Primary: 
time-to-delivery 
Secondary: 
Maternal and 
Neonatal adverse 
outcomes
Mode of delivery 
in 2nd birth
Risk of repeat CD
Birth experience in 2nd 
birth (visual  analogue 
scale 1-10) 
Risk of negative birth 
experience
Prediction of 
vaginal birth;
1) area under ROC
2) accuracy
3) sensitivity
4) specificity
5) 5-fold cross  
validation accuracy 
Methods Linear and logistic 
regression analysis 
Kaplan-Meier 
 analysis with 
 log-rank test
Poisson regression 
analysis
Linear and logistic 
regression analysis 
Imputation of missing 
variables, regression 
analysis, conditional 
inference tree and 
random forest, lasso 
binary regression
Confounders/
Predictors
Maternal age, height, 
BMI, year-of-delivery,  
delivery  hospital, 
gestational age, 
hypertensive 
 disease, diabetes, 
Bishop Score
Maternal age, height, 
BMI, gestational 
age, pregestational 
diabetes and preges-
tational hyper tensive 
disease at first 
pregnancy
Maternal age at 2nd 
birth, BMI, height 
and cohabiting at 
1st antenatal visit 
in 2nd pregnancy, 
 education, self-
assessed health at 
early 2nd  pregnancy, 
fear of childbirth in 
2nd pregnancy, birth 
experience and mode 
of delivery in 1st birth
Diagnoses and 
 procedures related to 
the pregnancy, labour, 
delivery and post-
partum for infant 1 
and related to preg-
nancy for infant 2 
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6.5 Ethical considerations and funding
Ethical research principles are based on and developed from the “Declaration of 
Helsinki” originally from 1964. These principles are for medical research involv-
ing human subjects, including research on identifiable human material and data. 
One of the most important statements is the following: “It is the duty of physicians 
who are involved in medical research to protect the life, health, dignity, integrity, 
right to self-determination, privacy, and confidentiality of personal information of 
research subjects. The responsibility for the protection of research subjects must 
always rest with the physician or other health care professionals and never with 
the research subjects, even though they have given consent.” 163
The Personal Data Act aims to protect personal integrity in the processing of per-
sonal data. In large population-based studies personal consent from participants 
is seldom required. In our studies no informed consent was collected, however, 
no results were presented on an individual level, and all data was anonymous. 
Important is also to weight the benefits and importance of the gained knowledge 
against the possible discomfort the studied individuals might experience. According 
to the Personal Data Act, research can only be conducted if ethical permission is 
given from one of the six ethical boards in Sweden.
Ethical approval for studies I, II and IV: The regional ethical committee at 
Karolinska Institutet, Stockholm, Sweden approved the study protocol (No. 
2009/275-31 and No. 2012/365-32), dates of approval April 2nd 2009 and March 
14th 2012.
Ethical approval for study III: The regional ethical committee at Karolinska 
Institutet, Stockholm, Sweden approved the study protocol (No. 2017/2385-31/5 
and No. 2018/1601-32), dates of approval January 11th and March 27th 2018.
Funding: This thesis with its included studies was funded through grants from the 
Swedish Research Council and grants provided by the Stockholm County Council. 
The funding sources had no role in study design, collection of data, analysis or 
interpretation of data, nor in decision to submit articles for publication.
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7 SUMMARY OF RESULTS
7.1 Time-to-delivery comparing induction methods (Study I)
In our dataset, 7551 nulliparous women were induced at or beyond term, with a singleton, 
live-born infant in cephalic presentation, and a Bishop Score below 7. Women induced 
with dinoprostone were generally older, less likely to smoke and had a more unripe 
 cervix and 25% had an additional induction method (balloon catheter or misoprostol). 
In women induced with misoprostol, 24% had a second induction method (balloon 
catheter or dinoprostone), while of the women induced with a balloon catheter only 1% 
needed an additional induction method (dinoprostone or misoprostol). Furthermore, 
women induced with a balloon catheter were more likely to have a Bishop Score >2 and 
received more epidural anaesthesia (79% versus 71-72%) and oxytocin augmentation, 
compared to women induced with the prostaglandin methods (94% versus 77-78%). 
The most common indication for labour induction was post-term pregnancy (32%).
In all vaginal deliveries and CDs carried out as a result of labour dystocia or failure 
of induction, mean-time-to-delivery was in comparison to dinoprostone, 2 h or 10 h 
shorter when the induction method was with misoprostol or balloon catheter respec-
tively (Model 1). When adjustment for the Bishop Score was also included, mean-
time-to-delivery was 1.5 h or 7 h shorter with misoprostol or a balloon catheter as the 
first induction method. When analyzing all deliveries (all vaginal and all caesarean 
deliveries), time-to-delivery was overall shorter, but the time-to-delivery relation 
between the three induction methods was unchanged (Table 7.1).
Table 7.1. Time (hours) from induction start to delivery by induction method
Induction method Model 11 Model 22
Crude 
Mean
Adjusted 
Mean 
β (95% CI) Adjusted 
Mean 
β (95% CI)
Vaginal deliveries and caesarean deliveries due to labour dystocia and induction failure
Dinoprostone 25.20 25.25 Reference 24.08 Reference
Misoprostol 24.59 23.08 -2.17 (-2.94 to -1.41) 22.55 -1.53 (-2.29 to -0.77)
Balloon catheter 15.04 15.50 -9.75 (-10.30 to -9.20) 17.16 -6.93 (-7.57 to -6.28)
All deliveries
Dinoprostone 24.41 24.53 Reference 23.50 Reference
Misoprostol 24.13 22.55 -1.98 (-2.70 to -1.26) 22.11 -1.39 (-2.11 to -0.67)
Balloon catheter 14.87 15.32 -9.21 (-9.73 to -8.70) 16.80 -6.70 (-7.31 to -6.09)
1 Model 1: adjusted for maternal age, height, body mass index (BMI), year of delivery, hospital, 
 gestational age, hypertensive disease and diabetes
2 Model 2: adjusted for maternal age, height, body mass index (BMI), year of delivery, hospital, 
 gestational age, hypertensive disease, diabetes and Bishop Score
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We could see that there was an interaction between the Bishop Score and time-to-
delivery for balloon catheter versus dinoprostone (p-value <0.0001), but this interaction 
was not found in misoprostol versus dinoprostone (p-value = 0.76). When stratifying 
for Bishop Score into three groups (Bishop Score 0-2, 3-4, 5-6) and with Kaplan-Meier 
analyses including log-rank tests comparing time-to-delivery, there was a significant 
difference between the three induction methods (p-value <0.0001; Figure 7.1).
When analyzing associations between induction method and maternal and  neonatal 
outcome, we found that 94% of the women induced with a balloon catheter had 
 delivered within 24 h, whereas only 55% and 54% had delivered in the misoprostol 
and dinoprostone groups respectively. In addition, misoprostol had an association 
with a 24% increased risk of instrumental vaginal delivery compared to dinoprostone. 
There were no differences in risk of CD, maternal or neonatal complications in any 
of the three induction groups (Table 7.2).
Figure 7.1. Kaplan-Meier plots of crude time-to-delivery, stratified for Bishop Score 
Mean time: 
Bishop Score 0-2: Balloon 17 h, Dinoprostone 27 h, Misoprostol 28 h 
Bishop Score 3-4: Balloon 15 h, Dinoprostone 23 h, Misoprostol 23h 
Bishop Score 5-6: Balloon 14 h, Dinoprostone 21 h, Misoprostol 21 h
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7.2 Risk of repeat CD (study II)
Of the 5302 women eligible for trial of labour after one first CD, 41% had an 
ERCD, while the remaining 3116 women underwent a TOLAC (Figure 6.2.). 
Almost 70% of all the women going through a TOLAC had a vaginal birth, with 
the highest rates of VBAC when the first CD had been elective. When the first CD 
had been performed due to labour dystocia, the risk for repeated CD was almost 
double (aRR 1.96, 95% CI 1.69-2.27) compared to an elective first CD. (Table 7.3).
Table 7.3. Mode of delivery in 2nd birth and risk ratio for repeat caesarean in women with 
trial of labour after caesarean by indication of and cervical dilatation at 1st caesarean 
delivery
Mode of delivery 
in 2nd birth
Risk Ratio 
for repeat CD
Vaginal Caesarean Crude Adjustedc
n % n % cRR 95% CI aRR 95% CI
First caesarean delivery 2146 68.9 970 31.1
Elective CDa (Ref) 756 79.3 197 20.7 1.00 1.00
Unplanned CD 1390 64.3 773 35.7 1.73 1.51-1.98 1.64 1.43-1.89
Indications for unplanned CD
    Labour dystocia 550 56.2 429 43.8 2.12 1.84-2.45 1.96 1.69-2.27
    NRFWBb 535 67.4 259 32.6 1.58 1.35-1.85 1.48 1.26-1.75
    Other indications 305 78.2 85 21.8 1.05 0.84-1.32 1.05 0.84-1.32
Cervical dilation when labour dystocia
    ≤5 cm 130 45.3 157 54.7 2.65 2.25-3.11 2.48 2.09-2.94
    6-10 cm 256 57.5 189 42.5 2.05 1.74-2.42 1.98 1.67-2.35
    Fully dilated 157 68.6 72 31.4 1.52 1.21-1.91 1.46 1.15-1.86
    Missing 7 - 11 -
a CD: Caesarean delivery, b NRFW: Non reassured fetal well-being, cAdjusted for maternal age, 
height, body mass index (BMI), pregestational diabetes and pregestational hypertensive disease 
at 1st pregnancy
In women with a first labour dystocia, VBAC rates increased with increasing 
 cervical dilation before the first CD as well as the risk for repeat CD decreased, in 
comparison with women whose first CD had been elective (Table 7.3).
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When analysing the risk for repeat CD in association with the onset of second 
delivery together with the indication for first CD, the risk was highest in women 
with an induction in second delivery and unplanned first CD indication (aRR 1.97, 
95% CI 1.60-2.41) (Table 7.4). However, the possible effect modification by onset 
of second delivery was statistically significant (p=0.03).
Table 7.4. Crude and adjusted risk ratio for repeat caesarean delivery in women with 
TOLAC by indication of first caesarean delivery and onset of second delivery
Indication of 1st CD and 
Onset of 2nd delivery
Repeated 
CD 
Crude risk repeat CD Adjusted riska 
repeat CD
n % cRR 95% CI aRR 95% CI
Elective indication spontaneous 
onset (n=747) (Reference)
131 17.5 1.00 1.00
Unplanned indication spontaneous 
onset (n=1765)
598 33.9 1.93 1.63-2.29 1.81 1.53-2.14
Elective indication induction  
(n=206)
66 32.0 1.83 1.42-2.35 1.43 1.10-1.86
Unplanned indication induction  
(n=398)
175 44.0 2.51 2.07-3.03 1.97 1.60-2.41
a Adjusted for maternal age, height, body mass index (BMI), pregestational diabetes and 
pregestational hypertensive disease at 1st pregnancy
7.3 Risk of negative childbirth experience (Study III)
Out of the 780 women included in our study, 68% went through a trial of labour 
and 32% had an ERCD. Women in the ERCD group were older, had a higher 
level of education, their gestational age was lower and more feared childbirth in 
comparison with the TOLAC group. Of the women performing TOLAC, 70% had 
a vaginal birth (VBAC) and 30% had an unplanned repeat CD. Compared to the 
unplanned repeat CD group, women who succeeded with a VBAC were younger, 
taller, had a lower BMI, were more often cohabiting with the infant’s father and 
were non-smokers. Moreover, fewer were induced and the prevalence of fear of 
childbirth was lower.
The distribution of the rating of the birth experience for women giving birth a 
second time was skewed towards the higher numbers (Figure 7.2). More than 
60% of all women scored a birth experience of 8 or more, independently of mode 
of delivery for the 2nd birth. The mean birth experience in women with an ERCD 
was 8.8. After adjustment, women with a VBAC and unplanned repeat CD had a, 
0.5 (95% CI; -0.9 to -0.01) and 0.9 (95% CI; -1.5 to -0.3) lower mean difference 
of birth experience compared with women with an ERCD.
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Figure 7.2. Histogram of birth experience after 2nd birth by mode of delivery in 2nd birth; 
Elective repeat caesarean delivery (ERCD), vaginal birth after caesarean (VBAC) and 
unplanned repeat caesarean delivery (URCD) 
After adjusting for confounders, women giving birth by unplanned repeat CD had 
a five-fold increased risk of a negative birth experience (aOR 5.1, 95% CI; 1.5 to 
16.7) in comparison with women undergoing ERCD (Table 7.5). When stratifying 
for first birth, women with a first and a second unplanned CD were at greatest risk 
of a negative birth experience (crude OR 9.2, 95% CI; 2.1 to 40.0) in comparison 
with women with a first and a second elective CD.
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Table 7.5. Odds of negative birth experience by mode of delivery in 2nd birth, logistic 
regression
Mode of  delivery 
in 2nd birth**
Negative birth experience 2nd birth
Crude Model 1* Model 2*
n % OR 95% CI aOR 95% CI aOR 95% CI
ERCD 7 2.8 Reference Reference Reference
VBAC 44 11.8 4.6 2.0-10.4 4.5 1.7-11.9 2.3 0.7-7.3
URCD 27 16.9 7.0 3.0-16.4 7.4 2.7-20.3 5.1 1.5-16.7
* Adjustment in
Model 1: maternal age, height, BMI, cohabiting, education, self-assessed health in 2nd  pregnancy
Model 2: same as in Model 1 and fear of childbirth in 2nd pregnancy, birth experience after 1st 
birth and mode of delivery in 1st birth (elective vs unplanned CD)
**ERCD (elective repeat caesarean delivery), VBAC (vaginal birth after caesarean), URCD 
(unplanned repeat caesarean delivery)
7.4 Prediction of VBAC (Study IV)
 As in study II, of the 5302 women with a first CD and a subsequent delivery, 41% 
had an elective repeat CD. The remaining 3116 women performed a TOLAC, of 
whom 2146 women (69%) gave birth vaginally (VBAC) and 970 had an unplanned 
repeat CD (31%) (Figure 6.2).
Women delivering vaginally were more likely to be younger, taller, have a lower 
BMI and a lower change in BMI from the first to second pregnancy. They were 
more likely to deliver in a hospital with lower rate of unplanned CDs and have a 
spontaneous labour onset in the second delivery. Their second infant were more 
likely to be female. These women were less likely to have had labour dystocia as 
the indication of the first CD and were more likely to have had a spontaneous onset 
of first delivery and have reached second stage of labour before the CD or have an 
elective indication for the first CD. Further, they were more likely to have a lower 
gestational age, a smaller infant, and a shorter length of stay in the hospital after 
the first delivery, They were also less likely to have had a puerperal or postpartum 
infection in first delivery, and less likely to suffer from any hypertensive disorder 
in second pregnancy or any endocrine or lung disease at all. 
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AUROC ranged from 0.61 to 0.69, sensitivity was above 91% and specificity 
(the probability of correctly identifying a repeat CD) below 22% for all models 
(Table 7.6). In the validation dataset, the conditional inference tree assigned to 
every woman a probability of VBAC to >50%, giving a 100% sensitivity and 0% 
specificity. Accuracy (correctly classified delivery modes) ranged from 68% to 
70%, 5-fold cross-validation was similar.
Table 7.6. Predictive performance of existing and new predictive models, (95% CI)
Model AUROC* Accuracy Sensitivity Specificity 5-fold CV 
accuracy**
Grobman  
(original 
estimates)
0.64 
(0.61, 0.67)
69.9%  
(67.6%, 72.2%)
97.6%  
(96.7%, 98.5%)
7.1%  
(4.8%, 9.4%)
NA
Grobman  
(refit model)
0.64 
(0.61, 0.67)
69.9%  
(67.6%, 72.2%)
96.5%  
(95.4%, 97.6%)
9.6%  
(7.0%, 12.3%)
69.0%  
(67.4%, 70.7%)
Fagerberg  
(original 
estimates)
0.63 
(0.60, 0.66)
70.1%  
(67.8%, 72.4 %)
91.6%  
(89.9%, 93.2%)
21.4%  
(17.7%, 25.1%)
NA
Fagerberg  
(refit model)
0.66 
(0.63, 0.69)
70.7%  
(68.5%, 73.0%)
93.2%  
(91.8%, 94.7%)
19.7%  
(16.1%, 23.3%)
70.1%  
(68.5%, 71.7%)
Conditional 
inference 
tree
0.61 
(0.58, 0.63)
69.4%  
(67.1%, 71.7%)
100.0%  
(100.0%, 100.0%)
0.0%  
(0.0%, 0.0%)
68.4%  
(66.8%, 70.0%)
Random 
forest
0.69 
(0.66, 0.72)
70.0%  
(67.8%, 72.3%)
97.9%  
(97.0%, 98.7%)
6.9%  
(4.6%, 9.2%)
69.9%  
(68.3%, 71.5%)
Lasso 0.67 
(0.64, 0.70)
70.4%  
(68.1%, 72.7%)
93.4%  
(92.0%, 94.9%)
18.2%  
(14.8%, 21.7%)
70.4%  
(68.8%, 72.0%)
* AUROC: Area under the receiver-operating characteristics curve 
** 5-fold CV accuracy: five-fold cross-validation accuracy
In the calibration plots, all models other than the random forest model deviated 
from observed CD rates in the lower range of predicted probability (<50%), and 
all models had wide confidence bands in this lower range (Figure 7.3).
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Figure 7.3. Calibration plots of the different prediction models. The solid blue line rep-
resents the actual performance with dotted 95% confidence bands. Solid grey line is the 
ideal performance.
In the Grobman and Fagerberg models, 53% and 73% of women with an unplanned 
repeat CD had a predicted probability of VBAC above 60%. In the conditional 
inference tree, random forest, and lasso models, 97%, 61%, and 60% of women 
with unplanned repeat CDs had predicted probabilities of VBAC above 60% 
(Figure 7.4).
The conditional inference tree first split was at the indication for the first CD and 
the next split was at the presence of any hypertensive disorder during the second 
pregnancy. In the random forest, variables with the highest conditional impor-
tance included indication for the first CD, onset of labour in the first pregnancy 
(spontaneous, induction or planned CD), and maternal age, BMI and height. The 
strongest predictor in the lasso model was a single mother rather than one who 
was cohabiting in the first pregnancy. However, the model also selected indica-
tion of the first CD.
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Figure 7.4. Violin plot showing the distributions of predicted probability by observed 
VBAC status for existing and new models. A violin plot is a hybrid of a box plot and 
a kernel density plot; the box plot in the middle with its median, interquartile range 
and the rest of the distribution and on the side the kernel density plots showing the 
 distribution shape of the data.
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8 DISCUSSION
8.1 Main Findings
The time-to-delivery for nulliparous women induced with transcervical balloon 
catheter as the first induction method was almost seven hours shorter than for 
women induced with dinoprostone. Induction with misoprostol was associated with 
a time-to-delivery that was two hours shorter compared to dinoprostone, which 
may be of limited clinical importance. However, there was a 24% increased risk 
of instrumental vaginal delivery. None of the induction methods were associated 
with maternal or neonatal complications, or with increased CD rates, but all the 
women had overall high rates of CDs independent of the induction method.
Almost 70% of all women undergoing a TOLAC delivered vaginally. Women 
with an unplanned first CD had 64% increased risk of repeat CD in comparison 
with an elective first CD. Women with a first CD due to labour dystocia ran the 
greatest risk of a repeat CD. Among these women, a greater cervical dilation at 
the first CD was associated with an increased chance of a vaginal delivery in the 
subsequent birth.
Most women with a previous CD scored their birth experience as positive irre-
spective of the 2nd mode of delivery. However in comparison with women who had 
an ERCD, women with an unplanned repeat CD had a five-fold increased risk of a 
negative birth experience in the 2nd birth. Women with two subsequent unplanned 
CDs were at greatest risk for a negative birth experience.
Our newly developed machine learning models and the refitted previous existing 
regression models of predicting VBAC in women with only one previous birth, 
a caesarean, had AUROCs of 0.6-0.7. All the models demonstrated a high sensitiv-
ity in predicting vaginal delivery but with a low level of specificity, indicating that 
the prediction of an unplanned repeat CD was poor both for the classical regres-
sion models and for the machine learning models. Predictive performance was 
especially poor below 50% predicted probability, although the misclassification 
of unplanned repeat CDs spanned the whole range of predicted probability. The 
majority of women with an unplanned repeat CD had a predicted probability of 
VBAC above 60%. The original prediction models by Grobman138 and Fagerberg139 
had a slightly higher AUROC than those in our study, but included women with 
a previous vaginal birth, which is a strong predictor of VBAC.117 As we excluded 
women with the important predictor, a previous vaginal birth, probably made our 
prediction more difficult.
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8.2 Methodological considerations
Before applying results to other populations, alternative explanations for the 
found association with the exposure must be considered. First one should look 
at the validity of the study and study results. There are two sources of errors in 
epidemiological studies; systematic and random errors, and these ought to be 
investigated. After errors have been considered, we can proceed to considering 
the extent to which our results can be applied to other populations, external valid-
ity, or generalisability.
8.2.1 Study design
The major strength in all four studies in this thesis was the observational, pop-
ulation-based design, where the results derive from the entire population and 
represent the situation in that population. Our access to prospectively collected 
data in standardised electronic medical records with information about maternal 
characteristics, pregnancy and delivery information recorded by midwifes or obste-
tricians before the findings of our studies. This diminishes the risk of selection and 
recall bias. Thus the population-based design and the use of the electronic medical 
records strengthens external validity and generalisability through reduced selection 
bias. With the increasing use of electronic medical records in many countries, our 
approach is transferable to other contexts where medical records are digitalised. 
However, there can be a risk of low quality among the registers used in a study, 
and in general these registers are not based on the study questions nor the study 
design. Moreover, information in the registers is restricted to what has been entered 
in the registers. In our case, we are dependent on how rigorous the health care 
providers enter information into the medical records. However, population-based 
studies enable us to study rare outcomes and differences that are small as they 
cover large populations.
8.2.2 Systematic and random errors
Errors in epidemiological studies can either be systematic or random. Observational 
studies have the risk of systematic errors such as selection bias, information bias 
(misclassification), confounding, effect modification and interaction. These prob-
lems have to be avoided and planned for in the beginning of the research process.
Selection bias
Selection bias comes from the procedure of selecting or studying subjects, and from 
factors influencing study participation. When the exposure is assessed prospectively 
(in advance of the question studied), the risk of selection bias is diminished. In all 
our studies our exposures (induction method or previous indication for the first 
CD) were assessed before the outcomes (time-to-delivery, delivery mode, birth 
experience), thereby making our selection bias low.
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Information bias/ misclassification
Inaccurate recording and classification of exposures and outcomes can be informa-
tion bias or also called, misclassification. If misclassification is the same across 
the study groups it is random or non-differential, but, if it is unevenly distributed 
it is referred to as differential. The effect of a non-differential misclassification 
is that it reduces the differences between the groups and underestimates the true 
association. In contrast, differential, or non-random misclassifications introduce 
the possibility of biased estimates in any direction. One common differential 
misclassi fications is loss of follow-up, while another type is recall bias, when 
recall tends to differ according to disease status or outcome. In our studies there 
are risks of misclassifications, e.g. the indication for the CD reported by the on-
call obstetrician, or a surveillance bias due to having a different management of 
labour if the woman had a history of labour dystocia.
Confounding
Confounding is a central problem in epidemiologic research and occurs when the 
association between the exposure and outcome is affected by a third factor. Unlike 
other forms of bias, which are mainly introduced by the investigators or the study 
participants, confounding is the factor of complex interrelations between expo-
sures and outcomes. The confounding factor is related to both the exposure and 
the outcome, but may not be found in the causal pathway between exposure and 
outcome. If this is the case, it is an intermediate factor. Ideally, a confounder can 
be controlled for by randomization, since the confounders would then be equally 
distributed between study groups. In observational studies, we can reduce con-
founding by restrictions, matching, stratification or multivariable analysis.
Effect modification or interaction
Effect modification or interaction refers to when the observed strength of the 
association between exposure and outcome is affected by a third factor. Effect 
modification should have a plausible biological explanation and can be difficult to 
find. It is important that effect modification is discovered, and stratified analyses 
should be performed to present stratum-specific risk estimates.
Random error
In the absence of systematic errors (bias) observed results can be explained by 
chance. This is referred as random error. In epidemiological research, to assess the 
likelihood of random findings, it is usual to calculate a confidence interval for a 
risk estimate. This confidence interval is usually set to 95%, i.e. there is 95% prob-
ability that the association is not explained by chance when the confidence interval 
for a risk estimate does not include 1.00. Random errors depend on study size.
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8.2.3 External validity
Internal validity is related to the probability that observed associations are true for 
the study population itself, while external validity refers to whether results could be 
generalized to other populations. To generalize the results to other populations, it 
is of great importance that the internal validity is high through proper handling of 
bias. External validity is a matter of judgement and discussion, and it depends on 
the degree of similarity between the study population and the unstudied population.
8.2.4 Strengths and limitations in our studies
As described above, a strength of Study I is the population-based study design, 
and in addition, the large sample of more than 7500 induced nulliparous women 
that enabled us to study our outcomes with high statistical power and dimin-
ished the risk of random error. We restricted our analysis to vaginal deliveries 
and caesarean deliveries due to labour dystocia and induction failure. Excluding 
caesarean deliveries due to fetal distress (or non-reassurance of fetal well-being) 
is another strength of our study, since their inclusion would erroneously shorten 
time-to-delivery.
Studies II and IV were conducted in a context of universal maternity care, with 
only a small variation in the quality of care between hospitals, and a high rate for 
TOLAC. The relative equal chance for women to perform a TOLAC makes our 
results more representative, as they are not being affected by the selection that 
occurs in settings with much lower access to TOLAC. The short study period 
(2008-2014), constrains the sample size, but the likelihood of great differences in 
care over time decreases. An important strength in both studies is the large pro-
portion of women performing a TOLAC (almost 60%) of all eligible women, in 
comparison with international TOLAC rates (US 49%).106 This gives us adequate 
statistical power, and further, the fact that we included only women with one pre-
vious birth solidified our results, as previous vaginal birth affects VBAC rates.106
In study III the number of women performing a trial of labour and thereafter 
 succeeding with a VBAC was in line with our study II, conducted in another 
cohort, and also in line with other previous studies, strengthening the consistency 
and generalisability of this study.106 
Today most women are, in Sweden, asked to rate their experience of childbirth 
before being discharged from the delivery ward. Using the simple, accessible 
and understandable visual analogue scale (VAS) women score their overall birth 
experience. VAS is a valid prediction instrument of birth experience and has been 
shown to be a simple alternative to, and have a high correlation with, other birth 
experience scales (Wijma Delivery Experience Questionnaire B). It is shown to 
be consistent over time126, 164, and therefore we assumed that the likelihood of 
measurement bias was low when this method was used for screening. However, 
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birth experience naturally entails a variety of experiences and feelings in many 
different dimensions and deeper layers, and it can also change over time.120,165 For 
these reasons, it is important to be aware of the limitations of the VAS scale as a 
tool for deeper understanding of the experience of childbirth. So it may be con-
troversial to investigate the woman’s birth experience close to the childbirth and 
with so simple tools. However, this must be weighed against the high response 
rates, if scoring occurs before discharge, and the possibility to early find women 
with low rating of their birth experience.
The purpose of the Swedish Pregnancy Register is to collect data for improvement 
in both clinical quality and for research.157 However, as all studies are observa-
tional with data not collected and designed to the specific study questions, there 
is always a risk of residual confounding.
Study I has limitations typical of observational studies, specifically a risk of 
misclassification if the delivery was not registered as induction of labour, but the 
likelihood of this misclassification is uncommon and random. The use of oxytocin 
was higher in the balloon catheter group and we considered this as a mediator rather 
than a confounder, and consequently did not adjust for it. The choice of induction 
method was not done blind in our study and could possibly influence management 
of labour such as oxytocin augmentation. Further investigations are needed to study 
the use of oxytocin with different induction methods. Due to limitations in our 
data, we could not report the number of misoprostol dosages, cumulative oxytocin 
dose, occurrence of uterine tachysystole and need for tocolysis. We analysed our 
data on an “intention-to-treat” basis, based on the first induction method, even if 
induction was continued with a second or third method. This is a limitation but this 
is also the case with randomised trials. The health provider’s methods of choice 
vary and could influence our results, we adjusted for hospital and calendar year 
of birth, to minimize this bias. In many countries, misoprostol is not approved 
as a treatment for the induction of labour, and women seeking information may 
have found out about this as well as misoprostol’s possible adverse effects, thus 
introducing a selection bias.
The on-call obstetrician performing the first CDs in our different studies, reported 
the indication for the CD, while this does not eliminate the risk of misclassifica-
tion. As explained previously, to make the correct diagnosis for labour dystocia can 
be problematic in clinical practice since there are no strict definitions, and as an 
example to differentiate whether the arrest of labour was due to an induction failure 
or prolonged first stage can be difficult. But this is unlikely to be systematic and 
therefore more likely to be a non-differential misclassification. In addition, labour 
management could have been influenced by previous indications for the first CD 
as having a history of labour dystocia possibly leads to an earlier  decision of repeat 
CD, introducing surveillance bias, another form of misclassification. Moreover, 
even before labour, women could have been guaranteed an early decision for 
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repeat CD if signs of prolonged labour should appear. Furthermore, in study II, 
we have no report on childbirth experience from the first CD, an experience which 
could affect both TOLAC rates and also the likelihood of vaginal delivery.152 The 
preference for an elective repeat CD is multifactorial and contextual152 and can 
also depend on socio-economic status and background.166 These effects of selection 
bias are partly reduced by adjusting for confounders in the multivariate analysis. In 
none of the studies I, II and IV did we have any information on ethnicity, which 
could be an unmeasured confounder.167
In study II the effect modification was statistically significant meaning there 
could be a third factor affecting the association. Here this could indicate that, a 
woman whose labour needs to be induced already has a sign of abnormality, such 
as labour dystocia and therefore she has an increased risk of CD, and it is not the 
induction itself that increases this risk. 
In study III we included hospitals (12 of 42) with a VAS response rate of 80% 
or higher. However, these hospitals may not be representative on a nation basis 
and the small sample size is a limitation. Including all hospitals however would 
entail the risk of introducing a selection bias on an individual level, e.g. hospitals 
with low response rate may only ask women when birth experience was putatively 
negative. We compared women giving birth in included hospitals with and without 
a VAS score response, and found that women excluded due to no VAS response 
had similar maternal characteristics and birth outcomes as the women included in 
our study population. Therefore we concluded that to be scored with VAS in the 
eligible hospitals was a random selection. The study period in study II was short 
which confines the statistical power of our findings.
8.3 In the light of other studies
Study I
Our main finding in study I, that inducing nulliparous women with an unripe  cervix 
using the transcervical balloon catheter is associated with a shorter time from induc-
tion to delivery than using prostaglandins, is supported by a randomised controlled 
trial conducted by Prager et al.9 Contradictory results were seen in the randomised 
PROBAAT-II study which showed that that more women induced with misoprostol 
had delivered within 24 hours compared to women induced with a  balloon cath-
eter. However, after 36 hours, a larger proportion of women had delivered within 
the balloon catheter group.38 The contradictory results could be explained by the 
inclusion of women with mixed parity, different misoprostol dosages and inter-
vals of drug administration, and also less fluid filling the balloon catheter168, the 
length of time before the removal of the balloon catheter, and an induction pause 
during night. In our study we showed that inducing with misoprostol was associ-
ated with a greater risk of the need for an instrumental vaginal delivery, in line 
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with the PROBAAT-II study.38 In our study, there was a higher rate of maternal 
infections in the balloon catheter group, but in the adjusted analysis there was no 
significant difference, aligning with the results from both the PROBAAT-II study 
and a study by Aghideh et al.38, 169 Penell et al. showed lower pH in the umbilical 
cord blood and severe neonatal academia within the prostaglandin E2 gel group, 
compared with the single or double balloon catheter groups. This was interpreted 
as secondary to the increased rate of uterine hyperstimulation, a finding that was 
not confirmed in our study.10
Study II
Randomised controlled studies when studying TOLAC and ERCD are ethically 
dubious, which forces us to depend on results from observational studies. Almost 
60% of eligible women chose to attempt a vaginal birth in study II, a high rate in 
comparison with other countries.52, 95 Previous studies investigating the success 
rate of TOLAC in women with a history of labour dystocia have contradictory 
results. According to a study by Hoskins et al. only 13% of women delivered 
vaginally after a history of CD due to labour dystocia and a fully dilated cervix.108 
Kwon et al. concluded that in women with previous labour dystocia, the degree 
of cervical dilation did not affect the mode of delivery in a following TOLAC.110 
However, our study and four others convincingly show that cervical dilation in 
women with labour dystocia at the first CD is associated with the mode of delivery 
in the following delivery.109, 111, 112, 116 In line with results from Melamed et al. we 
also show that women with a first CD due to failed instrumental vaginal delivery 
had the same risk for repeat CD as all women with a first unplanned CD, and that 
these women also had a good chance of a VBAC (67.9%, aRR repeat CD 1.62; 
95% CI 1.22-2.15).114 67% of women performing TOLAC after a first CD due to 
non-reassuring fetal well-being delivered vaginally, which is in line with 68% in 
the study by Hoskins et al.108
In contrast to our study, most previous studies did not only include women with a 
first and second delivery. Including women with a previous vaginal delivery makes 
comparison and interpretation difficult when evaluating a TOLAC attempt.108, 
109, 111, 112, 114 Additionally, most of the studies mentioned were performed in a one 
centre hospital with local guidelines and practices for dealing with women with 
a previous CD, which probably affects the results. Our study population is based 
on seven different hospitals and covers around 25% of all births in Sweden, thus 
reducing the risk of bias in treatment and increasing the generalisability.
Study III
Our study III confirms and is in line with other studies that show that childbirth 
experience is associated with the delivery mode in women with a previous CD. 
Previous studies analysed the effect of an intervention program in women with a 
previous CD. The intervention consisted of counselling on mode of delivery and 
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birth outcome.134-136 These studies had small and clinical-based study populations, 
were subject to selection bias in opt-in or loss to follow up, or had unadjusted 
confounding of parity or gestational age.134-136 Cleary Goldman et al. concluded 
that women succeeding with a VBAC were most satisfied, but this difference from 
our results may be explained by the intervention program motivating women to 
try a TOLAC.134 Even Shorten et al. concluded that women with a spontaneous 
vaginal delivery were most satisfied. They asked women 6-8 weeks after delivery 
thereby giving them the possibility to have time for reflection and perhaps regret 
the choice of an ERCD. This could be a possible explanation to the difference 
to our results.135 However, previous studies do show a consistency of measured 
birth experience even after time has passed.164 Shorten et al. had large differences 
in VBAC success rates (48% versus 74%, expected VBAC rates are internation-
ally 60-80%53, 97) at different delivery units, reducing the generalisability of their 
study.135 Cleary Goldman et al. only enrolled 95 women of the 316 possible, which 
makes their study available for selection bias, and including premature births 
possibly affected birth experience.134 We included only women with one previous 
birth and both births at or beyond term. Mixing parity, preterm and term births 
introduces the risk of diluting the results. Emmet et al. excluded women who did 
not speak or understand English, which also limits generalisability. They also had 
a loss to follow up that consisted predominantly of women who were younger and 
had higher deprivations scores, introducing the risk of selection bias depending 
on socio-economic factors. However, the results of Emmet et al. were consistent 
with our results, showing that women with an unplanned repeat CD had the low-
est mean VAS score (mean 48.5, scale 0-100).136 But the mean rating was lower 
than in our study, possibly due to the context bias when a scale has more states 
of better or worse , with the risk of depressing or enhancing the values due to 
cognitive processes used by the respondents.170After a counselling program as in 
the above mentioned studies, awareness and knowledge may increase and birth 
experience here probably does not reflect the birth experience of a general popula-
tion, thus diminishing the generalisability of the results. In Sweden, most women 
are encouraged and recommended to perform a TOLAC after one previous CD, 
without attending any counselling program during pregnancy.
Study IV
In study IV we excluded women with an earlier vaginal delivery, a strong predic-
tor of VBAC. When comparing our results with the previously existing models by 
Grobman138 and Fagerberg139, our models would possibly have performed better 
if we had included women with a previous vaginal delivery. Moreover, despite 
the additional covariates in our dataset, our models did not perform better than 
previous classical models, and all today’s existing VBAC prediction models per-
form relatively poorly, indicating that there may also be other factors that affects 
TOLAC success at a patient, health provider, hospital, and country level, as previ-
ous literature provides support for.150, 171, 172
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9 CONCLUSIONS
• Transcervical balloon catheter was associated with a shorter length of labour, 
from the start of induction to delivery, in comparison to prostaglandins, with 
no difference in CD rates or adverse maternal or neonatal outcomes. (Study I)
• Almost 7 out of 10 women attempting TOLAC delivered vaginally, and even 
those with a history of labour dystocia had a good chance of vaginal delivery. 
Reaching a greater cervical dilation in previous birth may not be in vain, as 
the chance of VBAC is associated with greater cervical dilation. Women 
attempting a TOLAC might be selected on the basis of an indication for the 
first CD, but this requires further study. (Study II)
• Most women with a previous CD scored their childbirth experience as 
positive, independent of the second mode of delivery, a result that supports 
a TOLAC attempt. However, an unplanned repeat CD is associated with 
a negative childbirth experience. (Study III)
• Both classical regression models and machine learning models had a high 
sensitivity and a low specificity in predicting VBAC in women with only one 
previous birth, indicating that they are insufficient for predicting unplanned 
repeat CDs. Additional data covariates combined with machine learning 
techniques did not improve prediction compared with the classical regression 
models. VBAC is a difficult prediction problem, as both new and existing 
models misclassify unplanned repeat CDs across the spectrum of predicted 
probability. The indication for the first CD still seems to have the strongest 
association to TOLAC success, strengthening the use of this variable as a 
decision-maker for TOLAC and that we should emphasize improved birth 
outcomes in first-time mothers. (Study IV)
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10 FUTURE CHALLENGES
• Since time-to-delivery is an important factor and also an issue with which the 
clinics must deal with on a daily basis, it would be tempting to study further the 
effect of using both a transcervical balloon catheter and misoprostol together 
simutaneously. It would also be interesting to study how women experience 
this combined induction method with regards to pain and child birth experience, 
and to study the duration of delivery, delivery mode and adverse outcomes.
• At my clinic, we take care of the most extreme premature births in Stockholm 
and sometimes perform a caesarean on women that have only reached 24 
gestational weeks. To study these women and their next delivery, to study the 
TOLAC and VBAC rates, and their birth experience after a previous delivery 
with an adverse outcome such as an extremely premature birth, would be very 
interesting and challenging. It would also be valuable to study in more depth 
their risk of adverse outcomes as uterine rupture, haemorrhage, abruption, 
abnormal and invasive placentation.
• Further I would like to increase our knowledge about the adverse event uterine 
rupture. Investigate why in Sweden the incidence is relative high. To study, 
when during labour the rupture occurs. And the effect of induction and oxytocin 
use on the risk of uterine rupture.
• Worldwide, hard work is currently underway with an aim to decrease CD rates. 
Would another form of care for women with a previous CD change the rate 
of women who dare to attempt a TOLAC? Could an intervention program to 
inform and educate both the women and the health care providers (midwives and 
obstetricians) decrease the rate of repeat CDs? Would this change the women’s 
childbirth experiences in a more positive direction? Future studies could aim 
to study women with a previous CD, how to screen them for their childbirth 
experience, and if they should be offered counselling before and after birth.
• To predict VBAC would help us in our work motivating and selecting women to 
undergo a TOLAC. But can we really predict VBAC? Are the existing prediction 
models of any use? Do obstetricians and midvives more accurately predict an 
individual women’s chances of VBAC than the prediction models that we have 
today? Future research should focus on prospectively testing different models 
for predicting VBAC. 
• The increasing rate of CDs contributes to the increasing number of women with 
an invasive placenta. To decide which treatment the woman should undergo 
is a challenge. It is of great importance to study this, in order to improve birth 
management for these women.
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11 POPULÄRVETENSKAPLIG 
SAMMANFATTNING
Att föda barn är en unik händelse i en kvinnas liv, många ser fram emot förloss-
ningen med blandade känslor av förväntan, glädje och ofta även rädsla. Förloss-
ningen kan påverka kvinnan både fysiskt och psykiskt, och kan även påverka 
barnets hälsa.120-124 Sjukvårdens uppgift är att stödja och hjälpa kvinnan under för-
lossningen. Målsättningen är att undvika onödiga ingripanden, med så låg risk som 
möjligt för komplikationer i form av sjukdom och död hos kvinnan eller barnet.71
Igångsättning av förlossning (induktion) är en vanlig intervention inom förloss-
ningsvården, som har ökat under de senaste decennierna. Idag induceras 19% av 
alla förlossningar i Sverige.6, 12, 13 Målet med induktion är att kvinnan ska föda 
vaginalt innan förlossningen startar spontant. De risker som finns med induktion 
måste vägas mot de risker som finns för mor och barn att avvakta spontan start.6 För 
cirka 10-25% av alla kvinnor som föder sitt första barn med inducerad förlossning, 
avslutas förlossningen med ett kejsarsnitt.12 Även kejsarsnitt är en intervention 
som ökat stadigt de senaste decennierna. Idag avslutas 18% av alla graviditeter i 
Sverige med ett kejsarsnitt.2, 5 Orsaken till att inducera en förlossning eller utföra 
ett kejsarsnitt är ofta densamma eller är sammanlänkade. I förlossningar, efter 
tidigare förlossning med kejsarsnitt, har kvinnorna och barnet de väntar en ökad 
risk för komplikationer under såväl graviditeten som under förlossningen.52, 95, 97
I de flesta länder anses det säkert för kvinnor, med ett tidigare kejsarsnitt, att föda 
vaginalt vid efterföljande förlossning.53, 97, 104 När kvinnan försöker föda vaginalt, 
avslutas förlossningen med antingen en vaginal förlossning eller ett upprepat 
kejsar snitt. Risken för komplikationer vid försök att föda vaginalt är dock förhöjd. 
Till exempel kan det gamla kejsarsnittsärret på livmodern brista (uterusruptur) 
med risk för allvarliga komplikationer hos både kvinnan och barnet. Frekvensen 
uterusruptur varierar något. I en stor amerikansk studie från 2004 fick 0.7% av 
17 898 kvinnor, som försökte föda vaginalt, efter ett tidigare kejsarsnitt, en uterus-
ruptur. I samma studie, ådrog sig12 barn hjärnskador på grund av syrebrist under 
förlossningen. Hos 7 av barnen berodde syrebristen på uterusruptur. I en svensk 
undersökning fick 1.3% av kvinnorna med ett tidigare kejsarsnitt en uterusrup-
tur.96 Komplikationer utöver uterusruptur uppstår till större del hos kvinnorna som 
genomgår ett upprepat kejsarsnitt, t.ex. infektion i livmodern eller stora blödningar 
med behov av blodtransusioner.95 Många kvinnor vill inte föda vaginalt efter ett 
tidigare kejsarsnitt och väljer därför ett planerat kejsarsnitt. Men även ett planerat 
kejsarsnitt innebär en ökad risk för komplikationer såsom infektioner, större blöd-
ning, borttagning av livmodern, blodpropp och till och med död hos kvinnan. 91
63
Det övergripande syftet med denna avhandling är att öka kunskapen om hur det 
går för kvinnor, som föder sitt andra barn efter ett tidigare kejsarsnitt. Mina med-
författare i de olika studierna och jag har studerat sambandet mellan orsaken till 
kejsarsnitt i den första förlossningen och förlossningssättet i den andra förlossningen, 
samt risken för ett upprepat kejsarsnitt och en negativ förlossningsupplevelse. Därtill 
har vi, med hjälp av artificiell intelligens, utvecklat modeller för att beräkna varje 
kvinnas individuella chans att föda vaginalt efter ett tidigare kejsarsnitt.
Eftersom 10-25% av alla förstföderskor i Sverige som induceras föder med kejsar-
snitt12, jämförde vi tre olika induktionsmetoders tid från induktion till förlossning 
och respektive metods risk för kejsarsnitt.
Studie I: Tid till förlossning efter induktion och risk för kejsarsnitt, 
 jämförelse utav tre metoder
I studie I undersöktes 7551 förstföderskor, som blev inducerade i Stockholm eller 
Gotland mellan 2008 och 2014. Kvinnornas barn var fullgångna, låg i huvudbjud-
ning och föddes levande. Eftersom kvinnornas livmoderhals var omogen för för-
lossning, inducerades de med en av följande tre metoder; 1) vaginalt applicerad 
dinoprostone (vår referensmetod enligt för tiden gällande riktlinjer) 2) oral tablett 
misoprostol 3) ballongkateter. Både dinoprostone och misoprostol är prostaglan-
diner, ett läkemedel som mjukar upp livmoderhalsen. Ballongkatetern som app-
liceras genom livmoderhalsen och fylls med vätska ovanför inre modermunnen, 
genererar ett mekaniskt tryck på livmoderhalsen samt stimulerar kvinnans egna 
hormoner att utsöndras för att få livmoderhalsen att mogna inför förlossningen.
Resultaten visade att tiden från induktion till förlossning var knappt sju timmar 
kortare med ballongkateter i jämförelse med dinoprostone. Vid jämförelse  mellan 
dinoprostone och misoprostol var tiden två timmar kortare med misoprostol. 
Detta efter att vi korrigerat resultaten för andra faktorer som kan påverka tiden 
till förlossning. 
Av kvinnorna som erhöll ballong födde 95% inom 24 timmar. Av de som erhöll 
misoprostol födde endast 55% inom 24 timmar, och för de som fick dinoprostone 
endast 54 % inom 24 timmar. Vi fann ingen skillnad i antalet kejsarsnitt mellan de 
tre metoderna, men misoprostol var associerat med 24% högre risk för förlossning 
med sugklocka jämfört med dinoprostone.
Studie2: Risk för upprepat kejsarsnitt
I studie 2 födde 5302 kvinnor mellan 2008 och 2014 både sitt första och andra 
barn i Stockholm eller på Gotland. Det första barnet föddes antingen med plane-
rat eller akut kejsarsnitt. Inför den andra förlossningen var barnen fullgångna, låg 
i huvudbjudning och föddes levande. Av dessa 5302 kvinnor var det drygt 41% 
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som direkt valde ett planerat kejsarsnitt inför andra förlossningen. Resterande 59% 
(3116 kvinnor) försökte föda vaginalt. Dessa kvinnor utgjorde vår studiepopulation.
Vi fann att av alla kvinnor i studiepopulationen födde till slut 69% vaginalt. De 
kvinnor som hade ett första planerat kejsarsnitt födde till största del vaginalt i andra 
förlossningen. I jämförelse med kvinnorna som hade ett första planerat kejsar-
snitt löpte de kvinnor som kejsarsnittades akut på grund av värksvaghet nästan 
dubbelt så stor risk för upprepat kejsarsnitt vid andra förlossningen. Hos kvinnor 
med värksvaghet vid första kejsarsnittet fann vi ett samband mellan hur mycket 
livmoderhalsen öppnade sig före förlossningen avbröts, och risken för upprepat 
kejsarsnitt. Risken för upprepat kejsarsnitt var högst hos kvinnor med ett första 
akut kejsarsnitt och induktion av andra förlossningen.
Studie III: Risk för negativ förlossningsupplevelse
I studie III använde vi oss av Graviditetsregistret, ett nytt register sedan 2013 och 
med idag 98,5% av Sveriges alla förlossningar registrerade.12, 156 Vi studerade 
kvinnor med ett tidigare kejsarsnitt och deras förlossningsupplevelse i andra för-
lossningen. Vid många av förlossningsklinikerna i Sverige ber man den nyförlösta 
kvinnan skatta sin förlossningsupplevelse innan hon lämnar kliniken. På klini-
kerna används en enkel, lättförståelig, visuell analog skala (VAS) där kvinnan 
ger ett poäng mellan 1 och 10, där 1 är värsta tänkbara och 10 är bästa tänkbara 
förlossningsupplevelse. Vid våra första analyser fann vi att vissa regioner hade låg 
svarsfrekvens av förlossningsupplevelsen och andra regioner hade omvänd tolk-
ning av VAS-skalan. Vi sorterade därför bort klinikerna med omvänd tolkning av 
VAS-skalan och även alla kliniker med en svarsfrekvens som var lägre än 80% 
sorterades bort. Av de 42 kliniker som fanns registrerade i Graviditetsregistret 
hade vi slutligen endast 12 kliniker kvar, med sammanlagt 780 kvinnor, som fött 
både sitt första och andra barn vid någon av dessa kliniker under 2014-2017. 
Dessa kvinnor utgjorde vår studiepopulation. De inkluderade klinikerna var jämt 
spridda över Sverige och utgjorde en blandning av såväl universitetskliniker som 
mindre förlossningskliniker.
Även i denna studie såg vi att sju av tio kvinnor som försökte föda vaginalt efter 
ett första kejsarsnitt födde vaginalt vid andra förlossningen. Oavsett förlossnings-
sätt vid andra förlossningen skattade de flesta kvinnor sin förlossningsupplevelse 
högt, med VAS poäng 8 eller högre. Sedan tidigare är det visat att ca 10% av alla 
kvinnor upplever sin förlossning som negativ.120, 159 I vår studie hade 10% av alla 
kvinnor skattat förlossningen till 5 poäng eller lägre, således satte vi gränsen för 
negativ förlossningsupplevelse vid 5 poäng eller lägre.
I jämförelse med kvinnor som födde andra barnet med planerat kejsarsnitt, fann vi 
att kvinnor som födde sitt andra barn med akut kejsarsnitt var risken för negativ 
förlossningsupplevelse upp till 5 gånger högre.
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Studie IV: Prediktion av vaginal förlossning hos tidigare kejsarsnittade 
kvinnor
I studie IV studerade vi samma population som i studie II och som bestod av 3116 
tidigare kejsarsnittade kvinnor som försökte föda sitt andra barn vaginalt. Med 
hjälp av artificiell intelligens utvecklade vi tre olika modeller för att försöka förut-
säga (predicera) den enskilda kvinnans möjligheter att föda vaginalt efter endast ett 
tidigare kejsarsnitt. Våra nya modeller jämförde vi med en äldre modell utvecklad 
i USA (Grobmans modell138), som använder vanlig statistisk regressionsanalys för 
prediktion. Vi jämförde även våra nya modeller med Fagerbergs modell139, en vidare-
utveckling av Grobmans modell, utvecklad för att användas i ett svenskt sammanhang. 
Både Grobmans och Fagerbergs modell anpassade vi till studiepopulationen i vår 
databas. Därefter jämförde vi de äldre modellerna med de nya avseende förmågan 
att predicera vaginal förlossning hos kvinnor med endast ett tidigare kejsarsnitt.
Våra resultat visade att alla modeller hade en hög sensitivitet d.v.s. hög förmåga 
att predicera vaginal förlossning. Samtliga modeller hade dock en låg  specificitet 
d.v.s. låg förmåga att förutsäga ett upprepat kejsarsnitt. Av den anledningen ana-
lyserade vi vidare. Vi fann, med Grobmans modell, att 53% av alla kvinnor som 
födde med upprepat kejsarsnitt hade egentligen blivit predicerade till mer än 60% 
chans att föda vaginalt. I Fagerbergs modell var 73% av kvinnorna med upprepat 
kejsarsnitt predicerade till mer än 60% chans att föda vaginalt. Våra nya modeller 
hade ungefär lika stor del felprediktion som Grobmans och Fagerbergs modeller. 
Våra nya modeller, utvecklade med hjälp av artificiell intelligens och avancerade 
statistiska metoder, med tillgång till en stor mängd information om kvinnornas 
graviditeter, tidigare förlossning och det första barnet förbättrade tyvärr inte 
prediktionen.
Slutsatser
• Induktion med ballongkateter var hos förstföderskor associerat med kortast 
tid till förlossning jämfört med prostaglandiner. Vi fann ingen skillnad mellan 
induktion med prostaglandiner eller ballongkateter i varken kejsarsnittsfrekvens 
eller andra allvarliga komplikationer hos mor eller barn.
• Nästan sju av tio kvinnor som försökte föda vaginalt efter ett tidigare kejsarsnitt 
födde vaginalt. Även om det första kejsarsnittet utfördes p.g.a. värksvaghet 
hade dessa kvinnor en god chans att föda vaginalt vid efterföljande förlossning. 
Störst chans av de värksvaga kvinnorna hade de vars livmoderhals öppnat sig 
mest innan det första kejsarsnittet utfördes. Kvinnor med tidigare kejsarsnitt 
kan möjligen selekteras för ett vaginalt förlossningsförsök beroende på orsaken 
till första kejsarsnittet.
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• De flesta kvinnor med ett tidigare kejsarsnitt var nöjda med sin nästföljande 
förlossning oavsett förlossningssätt. Men ett akut upprepat kejsarsnitt efter att 
ha försökt föda vaginalt var associerat med ökad risk för negativ förlossnings-
upplevelse. Kvinnor med tidigare kejsarsnitt kan vara en utsatt grupp och bör 
tillfrågas om sin förlossningsupplevelse och följas upp vid behov.
• Både klassiska prediktionsmodeller baserade på regressionanalys och våra nya 
modeller utvecklade med hjälp av artificiell intelligens, hade hög sensitivitet att 
predicera vaginal förlossning hos kvinnor med endast ett tidigare kejsarsnitt. 
Men samtliga modeller var dåliga på att förutse upprepat kejsarsnitt. Trots 
mängden data våra nyutvecklade modeller använde för att predicerade vaginal 
förlossning presterade de inte bättre än de äldre traditionella modellerna. Både 
de gamla och nya modellerna felklassificerar upprepat kejsarsnitt över hela 
prediktionsspektrat. Det verkar som om orsaken till första kejsarsnittet har den 
starkaste associationen till förlossningssätt vid nästa graviditet. Vi bör därför 
lägga mycket resurser på förstföderskans förlossning och förbättra hennes 
förlossningsutfall.
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